Podcasts about timone

VIDEO: I monaci di Norcia ➜ https://youtu.be/vVT1yzNXGUYTESTO DELL'ARTICOLO ➜ https://www.bastabugie.it/8125I MONACI BENEDETTINI DI NORCIA: CUSTODI DEL GREGORIANO E... DELLA BIRRA di Andrea Galli Grande festa oggi sulle colline appena fuori Norcia, in via Case Sparse. La comunità dei benedettini che lì risiede rende grazie per tre traguardi raggiunti. In primis i 25 anni di vita: la comunità fu fondata nel 1999 a Roma, dove ebbe i suoi inizi avventurosi prima di approdare fra i monti Sibillini. Poi la fine del restauro del complesso monastico, un antico convento dei cappuccini, dove i monaci si sono trasferiti dopo il terremoto del 2016 che ha distrutto il loro precedente monastero, contiguo alla concattedrale di Norcia. «Avevamo già comprato l'edificio e il terreno dalla diocesi, nel 2007 - spiega dom Benedetto Nivakoff - perché cercavamo un posto più tranquillo e silenzioso rispetto al centro di Norcia, ma il sisma ci ha costretti ad accelerare i nostri progetti». Infine l'elevazione canonica di quello che era tecnicamente un priorato benedettino e dallo scorso 25 maggio è un'abbazia, l'Abbazia di San Benedetto in Monte. Tre traguardi che insieme significano il ritorno pieno, ufficiale e stabile dei figli di san Benedetto nel luogo dove nacque il loro padre e padre del monachesimo d'Occidente, ma da dove gli ultimi benedettini se n'erano andati nel lontano 1810, a causa delle leggi napoleoniche, lasciando un vuoto che è stato riempito solo due secoli dopo, poco meno. A dimostrazione che le radici cristiane dell'Europa e anche delle nostre terre quando sembrano sofferenti, o financo morte, con la giusta linfa si possono riprendere più prontamente di quanto si pensi.La linfa in questo caso è arrivata tramite un religioso statunitense, Cassian Folsom. Nato nel 1955 a Lynn, nel Massachusetts, fattosi benedettino nell'abbazia di Saint Meinrad, nell'Indiana, padre Folsom venne in Italia per approfondire gli studi di liturgia e tra il 1997 e il 2000 ricoprì la carica di vice-rettore del Pontificio ateneo Sant'Anselmo (dove tuttora insegna). Nel 1995, mentre era su un treno diretto a Napoli, aveva avuto però l'ispirazione per un progetto extra accademico, ossia dar vita a una comunità che riprendesse il carisma e lo stile originario dell'ordine benedettino. La fondazione avvenne appunto a Roma nel 1999. Padre Folsom e tre benedettini americani si sistemarono in un piccolo appartamento nella capitale, con una stanza adibita a cappella. Nel 1999 la Santa Sede concesse loro l'approvazione canonica e nel 2000 si manifestò la possibilità di insediarsi a Norcia. Nel 2001 un estimatore di padre Folsom, il cardinale Joseph Ratzinger, si recò in Umbria per celebrare con lui e i suoi confratelli la festa di san Benedetto: per tutti una conferma speciale del cammino intrapreso.«Oggi siamo venti monaci - spiega dom Nivakoff, originario di New York, eletto abate lo scorso 28 maggio - provenienti da dieci Paesi: Italia, Stati Uniti, Germania, Polonia, Portogallo, Gran Bretagna, Brasile, Indonesia, Slovenia e Canada. L'età media è di 30 anni». L'eterogeneità delle nazionalità si deve anche al fatto che all'abbazia arrivano pellegrini, turisti e curiosi da diverse parti del mondo, spesso approfittando di vacanze o viaggi di studio in Italia.Il ritorno alle origini del carisma si riflette nella scelta liturgica fondativa - il rito benedettino antico - in una vita di preghiera particolarmente esigente - sveglia alle 3,30 ogni mattina - e nel recupero degli antichi digiuni dell'ordine - un solo pasto al giorno tra il 15 settembre e il tempo di Pasqua. Ora et labora. Per quanto riguardo il labora, tra l'altro i monaci di Norcia hanno elaborato da una decina d'anni la Birra Nursia, che porta come motto Ut laetificet cor, il prodotto con cui cercano di essere autosufficienti e che si inserisce in una tradizione gloriosa di birre monastiche. «Ora che abbiamo completato il restauro del monastero - chiosa dom Nivakoff - potremo dedicarci con più impegno alla nostra birra, cercando anche di farla conoscere meglio». [...]Nota di BastaBugie: l'articolo dal titolo "Nursia, la birra dei monaci di Norcia vince tre volte" racconta come la birra dei monaci di Norcia sia diventata così apprezzata nel mondo.Ecco l'articolo completo pubblicato sul Sito del Timone il 3 aprile 2025:La prima sede di Birra Nursia, situata accanto alla Basilica di San Benedetto a Norcia, è stata resa inagibile dai terremoti del 2016. Ma i discepoli di San Benedetto che vivono nella sua città natale non hanno mollato il loro "pane liquido", come veniva chiamata la birra nei monasteri durante i periodi di digiuno.Ed ora, che vivono nel ristrutturato monastero di San Benedetto in Monte, da poco elevato ad Abbazia, si godono i premi che la loro Birra Nursia ha raggiunto. Untappd, la più rilevante community al mondo nel settore delle birre artigianali, ha premiato Birra Nursia Tripel con la medaglia d'oro come migliore Belgian Tripel italiana, Birra Nursia Bionda con l'argento come seconda Belgian Blonde del Paese e Birra Nursia Extra, già considerata "imperdibile" da Slow Food, con il bronzo come terza Belgian Strong Dark Ale prodotta nello Stivale. Questi riconoscimenti arrivano in occasione degli Untappd Community Awards e si basano su migliaia di recensioni offerte da esperti e appassionati di birra.Birra Nursia è prodotta dal 2012 dai monaci benedettini di Norcia e le sue tre ricette sono state sviluppate nel solco dell'antica tradizione birraria monastica belga. La sua lavorazione avviene con metodi artigianali, attraverso un processo lungo e attento e facendo uso di ingredienti selezionati tra cui il malto umbro. Dopo il terremoto del 2016 è iniziata un'amichevole collaborazione tra la comunità benedettina e Mastri Birrai Umbri. Affinché Birra Nursia potesse continuare a essere apprezzata in Umbria, in Italia e all'estero, il birrificio di Gualdo Cattaneo ha offerto ai monaci di utilizzare i suoi impianti, a una sola condizione: che fossero i monaci stessi a produrre la birra, per garantire l'autenticità del prodotto e il rispetto delle ricette originali.«Birra Nursia», dice Dom Agostino Wilmeth, monaco dell'Abbazia di San Benedetto in Monte e mastro birraio di Birra Nursia, «è nata dall'idea che una buona bevanda potesse accompagnare le prelibatezze gastronomiche di Norcia, conosciute in tutto il mondo. La nostra birra sostiene la vita dell'Abbazia ma contribuisce anche all'economia della città, che ha tanto sofferto nell'ultimo decennio. Vorremmo condividere simbolicamente questi premi con tutti i nursini: la qualità e la tradizione sono valori forti nella Regola di San Benedetto e qui a Norcia, e Birra Nursia li ha ricevuti in eredità».

Des heures d'attente aux urgences ? Ce n'est pas une vue de l'esprit, bien au contraire : le délai qui s'écoule entre l'arrivée d'un patient dans le service et sa sortie est de 5h et 9 minutes en moyenne ; c'était "seulement" 3h59 en 2013, autrement dit 1h et 10 minutes de plus en 10 ans. Des chiffres donnés par la direction statistique des ministères sociaux, la DREES. Nous vous emmenons aux urgences de la Timone, à Marseille grâce à Etienne Baudu.Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

1er épisode / 5, de la série sur la maladie de Pompe. Episode 1 : Maladie rare – Qu'appelle-t-on maladie de Pompe ? Invité : Dr Emmanuelle Salort-Campana, neurologue, praticien hospitalier à l'hôpital de la Timone, à Marseille, clinicien du centre de référence des pathologies neuromusculaires PACA Réunion Rhône-Alpes de la filière Filnemus, membre du groupe de rédaction du PNDS sur la maladie de Pompe, réalisé avec les filières FILEMEMUS et G2M. http://fr.ap-hm.fr/service/maladies-neuromusculaires-et-sla-hopital-timone https://www.filnemus.fr/  https://www.filiere-g2m.fr/    1️⃣   Qu'appelle-t-on maladie de Pompe ? [0'34 – 1'30] ✔️ Glycogénose de type 2, maladie musculaire due à un déficit enzymatique. ✔️Parmi les premières maladies neuromusculaires à bénéficier d'un traitement. ✔️ Environ 290 cas recensés en France. Pour plus d'informations, retrouvez notre page article : https://rarealecoute.com/maladie-de-pompe-glycogenose-musculaire-de-type-ii/ 2️⃣   Quelle est la physiopathologie de cette maladie rare ? [1'30 – 2'49] ✔️ Maladie due à des mutations génétiques, entraînant un déficit en alpha-glucosidase acide. ✔️ L'enzyme déficiente empêche la dégradation du glycogène, qui s'accumule dans les lysosomes des muscles squelettiques, cardiaques et lisses. 3️⃣   Quel tableau clinique doit faire suspecter la maladie de Pompe ? [2'49 -4'05] ✔️ Forme infantile sévère : cardiomyopathie, hypotonie, détresse respiratoire. ✔️ Forme tardive variée (début après 1 an) : faiblesse musculaire des ceintures, atteinte des muscles respiratoire, avec sévérité variable. 4️⃣   Quel est le pronostic de la maladie de Pompe ? [4'05 – 5'44] ✔️ Pronostic révolutionné avec l'apparition de traitements 5️⃣   À qui adresser les patients en cas de suspicion de la maladie de Pompe ? [4'05 – 6'20] ✔️ Signes d'alerte : faiblesse musculaire, augmentation des CPK, atteinte respiratoire. ✔️ Dépistage par un test accessible. ✔️Orientation vers un centre de référence de la filière Filnemus.   L'équipe : Virginie Druenne – Ambassadrice RARE à l'écoute Cyril Cassard – Journaliste/Animation Hervé Guillot - Production Crédits : Sonacom ****************************** À propos : "RARE à l'écoute" est un podcast dédié à la sensibilisation aux maladies rares et au soutien des personnes touchées par ces affections. Créé par un groupe passionné de professionnels de la santé, le podcast vise à informer les professionnels de santé et fournissant des informations sur les dernières avancées médicales et scientifiques dans le domaine des maladies rares, et inspirer les patients et leurs proches en partageant des histoires de courage et de persévérance. Contenu :

TESTO DELL'ARTICOLO ➜ https://www.bastabugie.it/it/articoli.php?id=8074LA FEDERAZIONE DI BOXE TIENE FUORI DAI MONDIALI FEMMINILI GLI UOMINI CHE SI SENTONO DONNE di Renzo Puccetti La medaglia d'oro per la boxe femminile delle olimpiadi di Parigi, non potrà partecipare al campionato del mondo che si terrà in Serbia il prossimo 8-16 marzo. Lo ha stabilito la International Boxing Association (IBA) sulla base dei risultati dei test effettuati sull'atleta nel 2023 che dimostrarono la presenza di un assetto cromosomico maschile ed elevati livelli di testosterone plasmatico. I risultati non furono presi in considerazione da parte del Comitato Olimpico Internazionale che lo additò "errato e illegittimo" e per questa decisione espulse l'IBA dall'organizzazione delle olimpiadi.In realtà il test non poteva essere messo in dubbio, essendo stato effettuato in maniera indipendente da due laboratori accreditati di due differenti Paesi, né d'altra parte il CIO produsse controanalisi che dimostrassero risultati diversi. Ciò che fu sufficiente per il Comitato Olimpico furono i documenti d'identità e i livelli ormonali entro gli intervalli accettati. Il presidente del CIO, il tedesco Thomas Bach, dichiarò: «Abbiamo due pugili che sono nate donne, hanno passaporti femminili, e hanno gareggiato come donne per anni. Questa è una chiara definizione di donna». Sì, una chiara definizione secondo la teoria gender, non la biologia.Allora si parlò soltanto dei risultati del corredo cromosomico, ma l'elemento aggiuntivo che sembra oggi emergere, è che anche i livelli ormonali non rientrassero nei parametri. Forse non accettando il test genetico, anche quello ormonale fu scartato dal Comitato Olimpico? Com'è poi finita la storia è arcinoto: il pugile di nazionalità algerina ha preso a cazzottoni tutte le rivali vincendo la medaglia d'oro e annunciando poi cause risarcitorie.Con l'arrivo di Trump alla Casa Bianca, il contesto si è capovolto. Sono stati firmati due ordini esecutivi che riconoscono l'esistenza di due soli generi stabiliti sulla base del sesso biologico, nelle scuole come nelle prigioni, nell'esercito, come nello sport, dove l'essenza etica non è l'inclusione, ma l'equità tra i contendenti; i pari si misurano con i pari e laddove la stazza e la forza sono essenziali, le donne gareggiano con le donne e i maschi con i maschi.Siamo al tramonto della follia gender? È presto per dirlo, ma la decisa marcia intrapresa negli USA offre qualche speranza anche da noi, dove purtroppo ancora oggi, nonostante i proclami pre-elettorali di Giorgia Meloni in terra spagnola nel 2022, "No alle lobby LGBT, No all'ideologia del gender", ribadito anche lo scorso anno, l'UNAR, ente dipendente dalla presidenza del Consiglio dei Ministri, bellamente continua a finanziare decine e decine di progetti delle organizzazioni LGBT. Aspettiamo un ordine esecutivo Trump style. Spes lata dea.Nota di BastaBugie: tra gli ordini esecutivi firmati da Trump, uno in particolare merita attenzione. Si tratta dell'ordinanza "Tenere gli uomini fuori dagli sport femminili" la cui applicazione si estende a tutti gli sport e a tutte le età. Il momento della firma, avvenuta il 5 febbraio, è stato immortalato con il presidente circondato di giovani e giovanissime atlete sorridenti. Il testo dell'ordine "Keeping Men Out of Women's Sports" stabilisce che siano revocati i fondi dai programmi educativi "che privano donne e ragazze di giuste opportunità sportive". L'ordine stabilisce anche che la politica della nazione sia quella di "opporsi alla partecipazione competitiva maschile negli sport femminili in senso più ampio". Trump ha ricordato quanto sia stato ingiusto, degradante e pericoloso per le donne permettere agli uomini di competere negli sport femminili dal momento che "nega loro pari opportunità di partecipare ed eccellere negli sport competitivi". Tale ordine esecutivo definisce maschio e femmina in base a criteri biologici: femmina è "una persona che appartiene, al momento del concepimento, al sesso che produce la grande cellula riproduttiva", mentre maschio è "una persona che appartiene, al momento del concepimento, al sesso che produce la piccola cellula riproduttiva". (fonte: Sito del Timone, 10 febbraio 2025)

Si è insediato l'altra sera il 47° presidente degli Stati Uniti, Donald Trump, inaugurando un mandato che promette di essere tutt'altro che noioso. Con un'economia americana in grande spolvero e dati che ne confermano la forza, il mondo osserva con interesse e non poche controversie l'inizio di questa nuova era politica.Quale sarà l'impatto globale e come reagirà l'Europa, tra crisi e opportunità?Di tutto questo parliamo nel podcast di oggi estratto dalla lettera settimanale di Salvatore Gaziano, fondatore di SoldiExpert SCF, società di consulenza finanziaria indipendente.E se volete ricevere analisi e approfondimenti non convenzionali sui mercati finanziari direttamente nella vostra casella di posta ogni martedì, iscrivetevi a letterasettimanale.it. 

Ecoutez Le Journal Inattendu avec Nathalie Renoux du 18 janvier 2025.

TESTO DELL'ARTICOLO ➜ https://www.bastabugie.it/it/articoli.php?id=8045OFFRE LA VITA PER SALVARE L'ANIMA DELL'ASSASSINO DI SUO PADRE di Rino Cammilleri Si chiamava Maria del Carmen Gonzàlez Valerio y Sàenz de Heredia. Perché un cognome così lungo? Perché sono due: gli spagnoli dei tempi cattolicissimi aggiungevano anche quello della madre, dimostrando alle femministe odierne di essere molto più "avanzati" di loro.Diciamo subito che si tratta di uno di quei bambini malatissimi che, inspiegabilmente (a viste umane), sono tutti per Gesù. E morendo non lasciano i genitori nello strazio, come la gioia serena della madre di Carlo Acutis dimostra. Se Dio ragionasse come noi, il Cielo sarebbe pieno di soli centenari. Eppure, anche i pagani sapevano che chi muore giovane è caro agli dei. E veniamo a noi. María del Carmen, così chiamata perché alla nascita consacrata alla Madonna del Carmelo, era madrilena e figlia di nobili. Era la seconda di cinque e nacque nel 1930.Dati i brutti tempi che correvano (e che di li a poco avrebbero portato alla guerra civile) si pensò di cresimarla alla svelta, cosa che fu effettuata quando lei aveva solo due anni per mano personale del nunzio apostolico Todeschini, che aveva consuetudine col cattolicissimo capofamiglia don Julio González Valerio. L'inferno scatenato dagli anarco -comunisti del Fronte popolare in quegli anni è cosa nota ai lettori del Timone (omicidi di preti, incendi di chiese, distruzione di opere d'arte religiose...), cosi saltiamo direttamente al 1936, quando la Spagna si divise in due parti, l'una contro l'altra armate. I miliziani rojos non persero tempo e scelsero proprio il giorno dell'Assunta per arrestare don Julio, che aveva il grado di capitano d'artiglieria. La colpa? Niente, semplice pulizia etnica, anzi religiosa: non era dei loro, quindi era contro di loro (diabolus simia Dei, il diavolo è la scimmia di Dio). Il carcere in cui lo rinchiusero dava sulla strada della sua casa, e la bimba poteva vedere sgomenta suo padre dietro a una finestra con le sbarre. Fino al giorno in cui non lo vide più. Alla moglie, che ne chiedeva notizie, fu risposto di andare a cercare all'obitorio.MISTERI DIVINIMaricarmen (così in famiglia), sebbene avesse solo sei anni sapeva che il responsabile ultimo dell'assassinio di suo padre era il premier repubblicanoManuel Azaña Díaz. Ma, beata innocenza, chiedeva a sua madre se l'anima di costui si sarebbe salvata (!). La madre, trattenendo le lacrime, le rispondeva che ci volevano molti fioretti. Intanto, sistemava i figli presso vari parenti e lei si rifugiava nell'ambasciata belga. Maricarmen fu messa in un collegio di suore irlandesi (tra le poche che i rivoluzionari lasciarono in pace, non volendo complicazioni internazionali). Ed era l'unica alunna a frequentare la Messa delle suore al mattino presto.Pare che durante la Settimana Santa, il Giovedì per l'esattezza, abbia offerto la sua vita a Dio in cambio dell'anima di chi l'aveva resa orfana. Qui non mi si chieda di avanzare spiegazioni, sarebbero un'arrampicata sugli specchi tanto inutile quanto fuorviante. Si tratta di mistica, della quale dichiariamo di nulla sapere e capire. Certo, sul retro di qualche santino si trova sempre il volo pindarico clericale che "spiega" l'inspiegabile. E l'inspiegabile è questo: come può venire in mente a una bambinetta di fare una cosa del genere e, per giunta, perseverarvi? Misteri divini. Sì, perché o così, o niente.Solo Dio può inculcare un desiderio siffatto, che implica una certezza adamantina nella realtà della vita eterna. Puoi stringere i denti e sopportare, sì, ma quando sai che la sofferenza è a termine. Come l'evangelica donna che partorisce e alla vista del neonato dimentica di aver patito da urlare.SAPEVA DI DOVER MORIREL'offerta di Maricarmen fu evidentemente accettata, infatti si prese la scarlattina. Era il 1939 e mancavano pochi mesi alla vittoria dei nazionalisti, che lei di fatto non vide mai. La scarlattina fece presto a degenerare in chissà che cosa: le si formò una specie di tumore all'orecchio, che si riempì di pus.Gli antibiotici ancora non esistevano, i medici non si raccapezzavano, cercavano di curala con certe flebo che però non bastavano mai. Prima tre volte al giorno, ed era roba dolorosa quando entrava in circolo. Arrivarono a venti al giorno. E ogni volta che l'ago le entrava nel braccio quella obbligava i presenti a dire un Pater noster con lei. Dopo otto giorni gettarono la spugna e la rimandarono a casa. La casa, però, era quella della zia Sofia, sorella della madre, la quale stava ancora, per sicurezza, nell'ambasciata belga. Qui gli agi di famiglia le permisero l'assistenza di due infermiere, ma era sempre peggio. Si ridusse a un'unica piaga in tutto il corpo. La madre la invitava a chiedere a Gesù la guarigione e lei diceva di star pregando perché si facesse la di Lui volontà. Sapeva di dover morire e, anzi, disse che le sarebbe piaciuto andarsene il giorno della Madonna del Carmine. Solo che, saputo che proprio allora si sarebbe sposata sua zia, posticipò. Infatti, come da lei predetto, morì il 17 luglio 1939, alle quindici, l'ora di Cristo. Lo stesso giorno, quattro anni prima, era scoppiata la guerra civile.IL PRIMO MIRACOLOAzaña? Morì l'anno dopo, in esilio a Montauban, in Francia. Il vescovo di Tolosa, monsignor Theas, gli impartì gli ultimi sacramenti e testimoniò che il presidente della Seconda repubblica spagnola era morto da buon cristiano. Grazie a una bambina di nove anni che si era sacrificata per lui. Anche santa Teresina di Lisieux, prima di entrare nel Carmelo a quindici anni (con dispensa speciale), aveva pregato per un famoso delinquente senzadio che, tra le bestemmie, stava offrendo il collo alla ghigliottina.E quello, un attimo prima, si era voltato verso il crocifisso che il cappellano gli tendeva e lo aveva baciato. Ma, con tutto il rispetto, santa Teresina non aveva offerto in cambio la sua vita (lo farà dopo, per i missionari), né quello le aveva ucciso il padre. La conversione di Azaña in articulo mortis fu solo il primo dei miracoli di Maricarmen, la cui efficace intercessione ha costretto i responsabili delle cliniche abortive di Madrid a chiedere l'intervento della polizia per il vistoso calo di affari.Il sito armatabianca.org registra diversi miracoli della piccola madrilena, andate a vedere. Giovanni Paolo II l'ha dichiara Venerabile. Per il momento.Nella sua borsetta da bimba c'era un'agendina di pelle rossa. Dentro frasi del tipo: «29 agosto. Oggi hanno ucciso mio padre», «Viva España, Viva Cristo Rey!», «6 aprile 1939. Mi sono offerta nella parrocchia del Buon Pastore». Faceva collezione di santini e giocava insegnando alle sue bambole a farsi il segno della croce. Sapeva a memoria il Rosario in latino e perfino le sterminate Litanie lauretane. Mari, prega per la nostra conversione.

Hoda and Jenna weigh in on the debates taking social media by storm. Also, Billy Eichner talks about his role as Timone in the Lion King prequel, Mufasa. Plus, style influencer Paige Desorbo gives her take on holiday accessories that will elevate any winter outfit. 

durée : 00:07:16 - Info médias - L'animatrice, qui a perdu son enfant lourdement handicapé l'an dernier, est retournée dans le service de neuropédiatrie où il a vécu ses derniers jours. Son documentaire "Samy et les anges de la Timone" est diffusé mardi soir sur France 2.

Un an après le décès de son fils, le vibrant hommage d'Églantine Éméyé au personnel soignant. Son documentaire “Samy et les anges de la Timone” est diffusé mardi 15 octobre à 22h55 sur France 2 : elle est l'invitée de C à Vous.Tous les soirs du lundi au vendredi à 19h sur France 5, Anne-Elisabeth Lemoine et toute son équipe accueillent celles et ceux qui font l'actualité du jour.

Nos invités du vendredi 11 octobre : Laurent Saint-Martin, ministre chargé du Budget et des Comptes publics et Églantine Éméyé dont le documentaire “Samy et les anges de la Timone” est diffusé mardi 15 octobre à 22h55 sur France 2.Avec également comme chaque soir L'édito de Patrick Cohen, La story de Mohamed Bouhafsi, Le 5 sur 5 de Lorrain Sénéchal.Tous les soirs du lundi au vendredi à 19h sur France 5, Anne-Elisabeth Lemoine et toute son équipe accueillent celles et ceux qui font l'actualité du jour.

À l'occasion de cette seconde émission enregistrée à Marseille, nous abordons précisément l'actualité médecine tropicale :  les flambées qui, ces derniers mois, ont mobilisé infectiologues, virologues, parasitologues et épidémiologiste. Mpox en Afrique centrale, Virus de Marburg au Rwanda, Choléra en Haïti & dans l'océan Indien, mais des épidémies moins médiatisées comme la leishmaniose cutanée, qui constitue un problème de santé publique dans l'ouest de l'Algérie. Nous aborderons évidemment la question-clé des vaccins, de la recherche vaccinale et de l'accès à la vaccination.   Pr Denis Malvy, infectiologue au service des maladies Infectieuses et Tropicales du CHU de Bordeaux et expert international dans la gestion de la crise sur Ebola. Membre du COVARS - Comité de veille et d'anticipation des risques sanitaires Dr Stanislas Rebaudet, médecin spécialiste en maladies infectieuses et tropicales à l'Hôpital Européen Marseille. Chercheur en épidémiologie à l'Institut des Sciences de la Santé Publique d'Aix-Marseille (ISSPAM) Dr Célestin Dembele, médecin généraliste au Centre de recherche et de formation sur le paludisme MRTC à Bamako au Mali. ► Émission délocalisée à Marseille, à l'occasion des « Actualités du Pharo », les rencontres francophones de médecine et de santé publique tropicales, à l'Hôpital de la Timone.Programmation musicale :► Juls & Masego - Perspective► Benjamin Clementine - I Won't Complain.

À l'occasion de cette seconde émission enregistrée à Marseille, nous abordons précisément l'actualité médecine tropicale :  les flambées qui, ces derniers mois, ont mobilisé infectiologues, virologues, parasitologues et épidémiologiste. Mpox en Afrique centrale, Virus de Marburg au Rwanda, Choléra en Haïti & dans l'océan Indien, mais des épidémies moins médiatisées comme la leishmaniose cutanée, qui constitue un problème de santé publique dans l'ouest de l'Algérie. Nous aborderons évidemment la question-clé des vaccins, de la recherche vaccinale et de l'accès à la vaccination.   Pr Denis Malvy, infectiologue au service des maladies Infectieuses et Tropicales du CHU de Bordeaux et expert international dans la gestion de la crise sur Ebola. Membre du COVARS - Comité de veille et d'anticipation des risques sanitaires Dr Stanislas Rebaudet, médecin spécialiste en maladies infectieuses et tropicales à l'Hôpital Européen Marseille. Chercheur en épidémiologie à l'Institut des Sciences de la Santé Publique d'Aix-Marseille (ISSPAM) Dr Célestin Dembele, médecin généraliste au Centre de recherche et de formation sur le paludisme MRTC à Bamako au Mali. ► Émission délocalisée à Marseille, à l'occasion des « Actualités du Pharo », les rencontres francophones de médecine et de santé publique tropicales, à l'Hôpital de la Timone.Programmation musicale :► Juls & Masego - Perspective► Benjamin Clementine - I Won't Complain.

À l'occasion de cette émission enregistrée à Marseille, à l'occasion des rencontres francophones de médecine de santé tropicale (qui ont eu lieu la semaine dernière dans la cité phocéenne), nous donnons la parole à des spécialistes de la médecine du sport, qui ont développé une expertise dans le contexte tropical, en intégrant des facteurs tels que l'hyperthermie et la thermorégulation, l'endurance en milieu chaud et humide. Dans le cadre de la lutte contre la sédentarité, nous aborderons la question de la promotion de l'activité physique en milieu tropical, de la sensibilisation des populations et des personnels soignants et du renforcement des moyens dédiés à l'activité sportive. Nous aborderons également la question du para-sport, vecteur d'inclusion sociale. Pr Xavier Bigard, médecin du sport et professeur agrégé du Val-de-Grâce à Paris. Directeur médical de l'Union cycliste international (fédération internationale de cyclisme) Pr Stéphane Bermon, médecin du sport et physiologiste de l'exercice. Il dirige le Département Sciences et Santé de World Athletics (la fédération internationale d'athlétisme) basée à Monaco Jean-Marie Aleokol Mabiémé, président de la Fédération camerounaise des sports pour déficients intellectuels et président du Conseil exécutif des jeux des personnes spéciales de l'Afrique francophone. Professeur certifié d'éducation physique et sportive. ► Émission délocalisée à Marseille, à l'occasion des « Actualités du Pharo », à l'Hôpital de la Timone.Programmation musicale :► Nancy Vieira -  Sol Di Nha Vida► Khadja Nin - Sambolera Mayi Son. 

À l'occasion de cette émission enregistrée à Marseille, à l'occasion des rencontres francophones de médecine de santé tropicale (qui ont eu lieu la semaine dernière dans la cité phocéenne), nous donnons la parole à des spécialistes de la médecine du sport, qui ont développé une expertise dans le contexte tropical, en intégrant des facteurs tels que l'hyperthermie et la thermorégulation, l'endurance en milieu chaud et humide. Dans le cadre de la lutte contre la sédentarité, nous aborderons la question de la promotion de l'activité physique en milieu tropical, de la sensibilisation des populations et des personnels soignants et du renforcement des moyens dédiés à l'activité sportive. Nous aborderons également la question du para-sport, vecteur d'inclusion sociale. Pr Xavier Bigard, médecin du sport et professeur agrégé du Val-de-Grâce à Paris. Directeur médical de l'Union cycliste international (fédération internationale de cyclisme) Pr Stéphane Bermon, médecin du sport et physiologiste de l'exercice. Il dirige le Département Sciences et Santé de World Athletics (la fédération internationale d'athlétisme) basée à Monaco Jean-Marie Aleokol Mabiémé, président de la Fédération camerounaise des sports pour déficients intellectuels et président du Conseil exécutif des jeux des personnes spéciales de l'Afrique francophone. Professeur certifié d'éducation physique et sportive. ► Émission délocalisée à Marseille, à l'occasion des « Actualités du Pharo », à l'Hôpital de la Timone.Programmation musicale :► Nancy Vieira -  Sol Di Nha Vida► Khadja Nin - Sambolera Mayi Son. 

Avvicendamento a sorpresa quello avvenuto nei giorni scorsi nell'unione Montana Alto Astico, dove al sindaco di Tonezza, Franco Bertagnoli, è succeduto quello di Laghi, Marco Lorenzato. A decretare il passaggio di consegne, un voto piuttosto compatto, con due sole astensioni ed un voto contrario.

Je reçois Guillaume Fond, Docteur en neuroimmunopharmacologie, enseignant et chercheur, expert en psychonutrition, pour parler de l'influence de l'alimentation sur la santé mentale.Le livre de Guillaume : https://www.odilejacob.fr/catalogue/sante-vie-pratique/forme-et-sante/bien-manger-pour-ne-plus-deprimer_9782415001582.phpMon site : https://www.fabricemidal.comFacebook Fabrice Midal : https://www.facebook.com/FabriceMidalFacebook du podcast Dialogues : https://www.facebook.com/dialogues.fmInstagram Fabrice Midal : https://www.instagram.com/fabricemidalInstagram du podcast Dialogues : https://www.instagram.com/dialogues.fmTiktok : https://www.tiktok.com/@fabricemidalMes trois chaînes YouTube :Mes vidéos : https://www.youtube.com/@FabriceMidal1Les Dialogues : https://www.youtube.com/@dialoguesfmLes méditations guidées : https://www.youtube.com/@mediteravecfabricemidalMes podcasts :Le podcast de Fabrice Midal (toutes mes vidéos en version audio) :

Les valises sont dans le couloir, les vacances sont dans la tête oui mais voilà, ce jour là Lisa a la varicelle…. Direction le médecin et quelque chose d'autre apparaît comme très inquiétant .Un examen et la confirmation que des signaux qui étaient là n'étaient pas anodins.Julie part avec Lisa, 20 mois , pour l'hôpital de la Timone, examens, observation, nuit à l'hôpital et le mot tombe c'est un cancer. Lisa qui a la varicelle est hospitalisée, en isolement. Très vite la décision de la chimio, la pose du PAC s'imposent.Une tumeur, de la taille d'un petit melon de cavaillon, sera décelée.Comment va être son enfance? Sa vie?Comment va t-elle surmonter tout cela?Dans cet épisode rempli d”émotions, parfois avec les larmes aux bord des yeux, Julie nous expose ce moment où la vie de Lisa bascule mais aussi à contre coup, la vie de toute la famille.Elle nous raconte par le menu les nouvelles étapes de leur vie., désormais tournée autour de ce cancer. Elle nous parle de ces sentiments qui la traversent, les états d'âme, la culpabilité avec laquelle elle se bat encore.De ce qu'elle fera de cette expérience et la manière dont sa vie professionnelle va évoluer avec de nouvelles envies.Comment Lisa, en grandissant voit grandir angoisse, sentiment d'injustice et peurs?Cet épisode aborde le cancer de l'enfant qui touche chaque année près de 2500 enfants de (0 à 17 ans) la mobilisation en faveur de la recherche pour les cancers pédiatriques , septembre en or, fait chaque année des avancées remarquables qui permettent de donner espoir et confort aux familles et aux enfants, n'oublions pas de nous mobiliser.Julie organise désormais en septembre un salon du bien-être https://www.facebook.com/myprod13 et récolte des fonds lors de septembre en or, en faveur de RESOP http://resop.net/, le réseau de soins en oncologie pédiatrique.La course du docteur Arnauld Verschuur - Ventoux contre le cancer -https://www.ventouxcontrecancer.fr/#CancerPédiatrique #Enfant #Famille #Recherche #SeptembreEnOrHébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

VIDEO: Premio Viva Maria alla Bussola Quotidiana ➜ https://www.youtube.com/watch?v=zT2AyJ4aBnATESTO DELL'ARTICOLO ➜ https://www.bastabugie.it/it/articoli.php?id=7704LA MADONNA DEL CONFORTO: LUCE IN TEMPI DI ATTACCO ALLA FEDE di Stefano ChiappaloneDurante la preghiera del Rosario che unisce ogni giorno la redazione e i lettori della Bussola, viene inquadrata una particolare immagine mariana: è la Madonna del Conforto venerata nel duomo di Arezzo in seguito a un evento miracoloso accaduto il 15 febbraio 1796. Quella presente nella nostra cappella è, naturalmente, una fedele riproduzione, ricevuta dal Centro Culturale "Amici del Timone" di Staggia Senese, che nel 2014, in occasione del 6° Giorno del Timone della Toscana, volle conferire a La Nuova Bussola Quotidiana il premio "Viva Maria".Torniamo al febbraio del 1796 ad Arezzo, nella cantina annessa all'Ospizio della Grancia, dove i camaldolesi vendevano il vino e mettevano a disposizione dei più poveri un fornello per cucinare e scaldarsi, accanto al quale si trovava proprio la nostra immagine, annerita e impolverata. Questa riproduceva a sua volta la Madonna di Provenzano, venerata a Siena (originariamente una Pietà di cui però era rimasto soltanto il busto della Vergine), accompagnata dalla scritta: «Sancta Maria ora pro nobis»). Quel mese di febbraio era iniziato male e il Carnevale era stato offuscato da decine di forti scosse di terremoto, accompagnate da bagliori e altri fenomeni inquietanti, che spinsero ben presto a volgere la baldoria carnevalesca in processioni penitenziali, anticipando la Quaresima che sarebbe iniziata ufficialmente il 10.SI RINFRANCHI IL TUO CUORE: ECCO TUA MADREIl 15 febbraio nuova scossa e nuovi timori: nella notte si ritrovarono in cantina alcuni artigiani, Antonio Tanti, Giuseppe Brandini e Antonio Scarpini, confidandosi i rispettivi timori per il terremoto insieme alla cantiniera Domitilla Bianchini. Il pensiero andò ben presto ai castighi divini e alla protezione di Maria. Accesero un lume alla malconcia immagine mariana che vegliava su di loro e cominciarono a pregare, quando d'un tratto quel bassorilievo - ormai giallo e nero, che non c'era più verso di ripulire - si fece candido, emanando una luce ben diversa dagli inquietanti bagliori del terremoto, che da allora cessò. La paura del sisma lasciò spazio alla meraviglia per il prodigio in sé e anche per alcune grazie e guarigioni attribuite all'immagine mariana, che nel giro di pochi giorni fu portata in duomo, dove gli aretini realizzarono poi un'apposita cappella dedicata alla Madonna del Conforto, cui si accede attraverso una cancellata sovrastata dalla scritta: «Confortetur cor tuum: ecce Mater tua» («Si rinfranchi il tuo cuore: ecco tua Madre»).Di lì a poco la Madonna del Conforto dovette prestare conforto agli aretini e a tutte le popolazioni toscane. In quello stesso 1796 Napoleone Bonaparte dava inizio alla Campagna d'Italia, volta ad esportare forzatamente i principi rivoluzionari nella penisola, laicizzandone le istituzioni: iniziava il cosiddetto "triennio giacobino" (1796-1799). L'invasione delle truppe napoleoniche fu accompagnata da una serie di prodigi ben ricostruiti da Vittorio Messori e Rino Cammilleri nel volume Gli occhi di Maria. Roma 1796: prodigi nell'Italia invasa da Napoleone (nuova ed. aggiornata, Edizioni Ares, Milano 2023). Da Ancona, dove si verificò il primo fenomeno il 25 giugno, a Todi, a Frosinone, passando per la Città Eterna, innumerevoli immagini mossero gli occhi o cambiarono espressione, quasi a lanciare un "allarme" celeste sulla persecuzione scatenata in nome dei "Lumi". Allarme di cui il fenomeno aretino costituisce non solo un preludio.IL PREMIO VIVA MARIAIn Toscana i principi rivoluzionari erano già nell'aria sotto il granducato di Pietro Leopoldo (asceso poi al trono imperiale nel 1790) e il "conciliabolo" tenuto dal vescovo giansenista di Pistoia, Scipione de' Ricci. Inizialmente il Granducato si era salvato dai francesi, che nel 1796 avevano preso la sola Livorno. Nel resto della penisola avevano già avviato il forzato "cambio di paradigma": via la croce, su l'albero della libertà, proclamando repubbliche ispirate ai nuovi ideali, non senza scatenare l'insurrezione - o meglio, l'insorgenza - delle popolazioni legate alle tradizioni e alla fede dei padri. Come avvenne anche in Toscana, quando il 25 marzo 1799 Firenze fu occupata dai francesi, che il 6 aprile giunsero ad Arezzo. E la popolazione insorse, al grido di "Viva Maria!", liberando il Granducato dagli occcupanti con la guida del diplomatico inglese William Frederic Wyndham, dell'ufficiale dei dragoni Lorenzo Mari... e della Madonna del Conforto, effigiata sui loro stendardi.Una storia e un'immagine che, pur nelle mutate circostanze, ci riguardano ancora da vicino: «Il premio», come scriveva nel 2014 don Stefano Bimbi, «è simbolicamente rappresentato da una perfetta riproduzione della Vergine del Conforto. Il motivo per cui è stato chiamato "Viva Maria!" questo premio è evidente: come ai tempi di Napoleone, è in atto un attacco alla fede cattolica. Ora come allora c'è bisogno che ci sia un forte movimento di popolo che difenda la Chiesa da questi attacchi». Quale che sia la buona battaglia (di ieri o di oggi), la Madonna del Conforto continua ad essere una luce per attraversare tempi oscuri.

Bienvenue sur RARE à l'écoute, la chaîne de podcast dédiée aux maladies rares. Pour cet épisode spécial dédié à la filière Filnemus, nous recevons le Pr Shahram Attarian, professeur des universités à la Faculté de médecine d'Aix-Marseille, praticien hospitalier, chef du service des Maladies Neuromusculaires et SLA à l'hôpital de la Timone à Marseille et coordonnateur de la filière Filnemus. Nous abordons aujourd'hui les objectifs de la filière Filnemus, les causes de l'errance diagnostique, ainsi que les premiers résultats obtenus suite au lancement du projet errance et impasse diagnostiques en 2019. Nous verrons également combien de patients sans diagnostic ont pu obtenir un diagnostic depuis le début de ce projet et quelles sont ses prochaines étapes. L'orateur n'a reçu aucune rémunération pour la réalisation de cet épisode.   Invité : Pr Shahram Attarian, professeur des universités à la Faculté de médecine d'Aix-Marseille, praticien hospitalier, chef du service des Maladies Neuromusculaires et SLA à l'hôpital de la Timone à Marseille et coordonnateur de la filière Filnemus http://fr.ap-hm.fr/service/maladies-neuromusculaires-et-sla-hopital-timone https://www.filnemus.fr/  L'équipe : Virginie Druenne - Programmation Cyril Cassard - Animation Hervé Guillot - Production Crédits : Sonacom

La nomina a premier di Donald Tusk è una svolta netta per la Polonia che così chiude un periodo all'insegna del nazionalismo per abbracciare una politica più europeista. Ne parliamo con Fabio Turco di Centrum Report.I ribelli Houthi colpiscono una nave norvegese nel Mar Rosso per perorare la causa palestinese. Ne parliamo con Alessio Patalano, professore di War & Strategy in East Asia al King's College di Londra, e con Enrica Fei, ricercatrice in Relazioni internazionali e Movimenti transnazionali sciiti presso l’Università Bundesweher di Monaco.

Les « Actualités du Pharo » sont un rendez-vous incontournable dans la recherche et la prise en charge des maladies tropicales. Des médecins et chercheurs des pays du Sud et du Nord se réunissent à Marseille pour faire un point sur les actualités de la médecine tropicale. Émission délocalisée à Marseille, à l'occasion des « Actualités du Pharo », les rencontres francophones de médecine et de santé publique tropicales, à l'Hôpital de la Timone. Qu'en est-il des alertes épidémiques récentes ? Quel est l'impact des morsures de serpent sur les populations vivant en zones rurales en République Centrafricaine ? Comment a été gérée la deuxième épidémie d'Ebola en Guinée ?   Pr Stéphane Jauréguiberry, infectiologue et chef de service des Maladies infectieuses et tropicales, à l'Hôpital Universitaire de Bicêtre au Kremlin-Bicêtre, en région parisienne (AP-HP) Dr Romaric Ghislain Zarambaud Bohy-Ngombet, enseignant-chercheur à l'École Doctorale des Sciences de la Santé Humaine et Vétérinaire à l'Université de Bangui, en République Centrafricaine   Bakary Doukouré, étudiant en Première année de thèse à l'Université allemande de Tübingen/Institut Pasteur de Guinée, il travaille sur l'épidémiologie d'hépatite E en Guinée au sein de l'Unité de Virologie de l'Institut Pasteur de Guinée, lauréat du Prix du travail de terrain des Actualités du Pharo.  Programmation musicale :► Femi Kuti – The way our lives go  ► Dowdelin – Simé love.

Les « Actualités du Pharo » sont un rendez-vous incontournable dans la recherche et la prise en charge des maladies tropicales. Des médecins et chercheurs des pays du Sud et du Nord se réunissent à Marseille pour faire un point sur les actualités de la médecine tropicale. Émission délocalisée à Marseille, à l'occasion des « Actualités du Pharo », les rencontres francophones de médecine et de santé publique tropicales, à l'Hôpital de la Timone. Qu'en est-il des alertes épidémiques récentes ? Quel est l'impact des morsures de serpent sur les populations vivant en zones rurales en République Centrafricaine ? Comment a été gérée la deuxième épidémie d'Ebola en Guinée ?   Pr Stéphane Jauréguiberry, infectiologue et chef de service des Maladies infectieuses et tropicales, à l'Hôpital Universitaire de Bicêtre au Kremlin-Bicêtre, en région parisienne (AP-HP) Dr Romaric Ghislain Zarambaud Bohy-Ngombet, enseignant-chercheur à l'École Doctorale des Sciences de la Santé Humaine et Vétérinaire à l'Université de Bangui, en République Centrafricaine   Bakary Doukouré, étudiant en Première année de thèse à l'Université allemande de Tübingen/Institut Pasteur de Guinée, il travaille sur l'épidémiologie d'hépatite E en Guinée au sein de l'Unité de Virologie de l'Institut Pasteur de Guinée, lauréat du Prix du travail de terrain des Actualités du Pharo.  Programmation musicale :► Femi Kuti – The way our lives go  ► Dowdelin – Simé love.

TESTO DELL'ARTICOLO ➜ https://www.bastabugie.it/it/articoli.php?id=7568IN OCCIDENTE GLI ISLAMICI FESTEGGIANO LE MILLE VITTIME DEGLI ATTACCHI DI HAMAS IN ISRAELE di Giuliano GuzzoLa guerra che infuria in Israele e a Gaza - con centinaia di vittime, feriti e ostaggi - è un orrore difficile da commentare; eppure offre spunti per riflessioni che non possono in alcun modo essere trascurate; anche perché si basano su fatti concreti. Un primo aspetto, già considerato ieri dal Timone, è quello del clamoroso e macroscopico fallimento dell'intelligence di Israele e Usa; un fallimento che pare inspiegabile, dato che, per le sue caratteristiche, l'operazione Tempesta deve necessariamente essere stata preparata per mesi - e proprio non si può pensare che a Gaza non vi siano uomini di Tel Aviv.Un secondo aspetto che deve far pensare - e che riguarda però stavolta non Israele né la Palestina, bensì l'Occidente - sono le numerosissime reazioni di giubilo e non solo, da parte di vari esponenti del mondo islamico, alla notizia dell'attacco di Hamas. Basti vedere cos'è accaduto all'High-Deck-Siedlung, area multiculturale che si trova nel quartiere Neukölln di Berlino: dei manifestati pro Palestina sono scesi in piazza per festeggiare i massacri di Hamas distribuendo dolci ai passanti e ci sono stati attacchi alla polizia, che hanno provocato il ferimento di due agenti e l'arresto di 40 persone.Attenzione a pensare che si tratti di un fenomeno solo tedesco. Anche in tutto il Regno Unito - a Londra, Manchester e Brighton - folle pro-Hamas si sono radunate per celebrare l'assalto ai danni di Israele. Scene simili si sono verificate anche in Svezia. Sabato scorso a Malmö, una città in cui il 37% della popolazione ha origini straniere, una carovana di palestinesi e altri migranti ha letteralmente invaso le strade; complessivamente, alla manifestazione hanno preso parte circa 200 autovetture, con musica araba e bandiere svolazzanti dai finestrini, quasi ci fosse da festeggiare un successo calcistico.Anche in Olanda ci sono state manifestazioni e i sindaci di Rotterdam e l'Aia si sono rifiutati di esporre la bandiera d'Israele. Scene surreali si son viste pure negli Stati Uniti e in Canada; significativo in particolare cosa è accaduto in Ontario, dove uomini a bordo di veicoli sono stati ripresi mentre celebravano gli attacchi nel parcheggio di un centro commerciale. Ora, si potrebbe continuare ancora a lungo enumerando avvenimenti che hanno dello sconvolgente, ma forse meglio fermarsi perché essi già mettono ben in luce - davanti ad una guerra che ieri ha superato la quota di 1.000 vittime - le basi civili inesistenti su cui poggia l'osannato modello sociale multiculturale, che ricorda tanto una bomba ad orologeria.Per carità, è vero che simili surreali festeggiamenti non costituiscono una novità assoluta. Basti vedere quanto accaduto nel 2015 in Siria, dove jihadisti dell'allora sedicente Stato islamico festeggiarono gli attentati di Parigi distribuendo caramelle alla gente in strada. Ma un conto - ecco la differenza - è che ciò sia avvenuto ieri, in Libia, per mano di militanti dell'Isis; un altro, ben più sconvolgente, è apprendere come le medesime scene si ripetano oggi nel cuore dell'Occidente, per mano di soggetti col passaporto europeo o americano. È un fortissimo campanello d'allarme. La domanda però è: quanti sapranno, in particolare nel mondo della politica e delle istituzioni, riconoscerlo come tale? Alla fine, la questione vera è tristemente questa.Nota di BastaBugie: Stefano Magni nell'articolo seguente dal titolo "Hamas, braccio palestinese dei Fratelli Musulmani" parla della matrice ideologica fondamentalista islamica del movimento armato palestinese che controlla Gaza. Un breve excursus storico sulle sue origini e progetti per il futuro.Ecco l'articolo completo pubblicato su La Nuova Bussola Quotidiana il 9 ottobre 2023:La guerra improvvisamente scatenata da Hamas contro Israele, inizia esattamente cinquant'anni dopo l'attacco arabo dello Yom Kippur, del 6 ottobre 1973. L'aggressione in un Paese addormentato in un sabato di festa, il fallimento dei servizi segreti, le gravi perdite degli israeliani, l'inaspettata preparazione dei suoi nemici la ricordano. Ma i paralleli finiscono qui. Perché quello a cui assistiamo, negli ultimi due giorni, non è un conflitto convenzionale fra eserciti regolari. È un'operazione a cavallo fra un'offensiva militare e un'azione terroristica, una "scorreria" tipica dei popoli del deserto e riportata in vita nei tempi moderni.Abbiamo visto scenari simili anche a Mumbai nel 2008 e più vicino a noi, nel tempo e nello spazio, anche a Parigi nel 2015. Gli attaccanti agiscono in piccole cellule fra loro coordinate, appoggiate da unità già all'interno del territorio nemico, colpiscono obiettivi civili indifesi, uccidono indiscriminatamente, catturano ostaggi (il loro vero "bottino"). Le massicce salve di razzi, la caratteristica di tutti i precedenti attacchi di Hamas, stavolta sono servite solo come diversivo. L'operazione vera e propria è avvenuta con l'infiltrazione di gruppi di terroristi nei centri abitati, compresa la città di Sderot.L'aspetto più atroce di questo tipo di azioni, oltre al trauma di chi le subisce in prima persona, è l'ostentazione della crudeltà. Le immagini dei civili uccisi, dei feriti, del sangue, dei cadaveri portati a Gaza come trofei, delle case penetrate e devastate, diventano "virali" sono fatte circolare in rete, sono montate ad arte, anche con la musica in certi casi. Deve servire per galvanizzare la propria base ideologica e al tempo stesso terrorizzare l'avversario. La popolazione colpita, soprattutto, sente di poter fare una fine atroce anche restando in casa propria e perde ogni senso di sicurezza.Al Qaeda e poi l'Isis, ci avevano abituati a questo tipo di spettacolo crudele, prima di sparire dai nostri radar. Hamas coglie alla sprovvista il pubblico occidentale più distratto, perché nessuno associava il partito islamista palestinese, padrone incontrastato di Gaza dal 2007, alla violenza tipica dei jihadisti. Ma la matrice ideologica di Hamas è la stessa di quella di Al Qaeda e dunque anche dell'Isis, scheggia impazzita del movimento di Al Zawahiri e Bin Laden. La matrice comune è quella dei Fratelli Musulmani (di cui l'ideologo Al Zawahiri era un esponente). E l'ideologia jihadista, anche quella di Hamas, non solo giustifica ma addirittura richiede l'uccisione dei civili nemici di religione. Colpisce gli ebrei in quanto tali, senza distinguere fra militari e non.Che Hamas sia il braccio palestinese dei Fratelli Musulmani è specificato nel suo stesso statuto del 1988. Nell'articolo 2 leggiamo: "Il Movimento di Resistenza Islamico è una delle branche dei Fratelli Musulmani in Palestina. Il movimento dei Fratelli Musulmani è un'organizzazione mondiale, uno dei più grandi movimenti islamici dell'era moderna. È caratterizzato dalla profonda comprensione, da nozioni precise, e da una totale padronanza di tutti i concetti islamici in tutti i settori della vita: nelle visioni e nelle credenze, in politica e in economia, nell'educazione e nella società, nel diritto e nella legge, nell'apologetica e nella dottrina, nella comunicazione e nell'arte, nelle cose visibili e in quelle invisibili, e comunque in ogni altra sfera della vita".Nel suo preambolo è contenuta una citazione di Hassan al Banna, fondatore egiziano della Fratellanza: "Israele sarà stabilito, e rimarrà in esistenza finché l'islam non lo ponga nel nulla, così come ha posto nel nulla altri che furono prima di lui". Oltre a questo invito a distruggere lo Stato israeliano, troviamo nello stesso statuto anche quello a uccidere gli ebrei. L'articolo 7, sulla Universalità del Movimento di Resistenza Islamico, è diventato tristemente celebre: "... il Movimento di Resistenza Islamico ha sempre cercato di corrispondere alle promesse di Allah, senza chiedersi quanto tempo ci sarebbe voluto. Il Profeta - le preghiere e la pace di Allah siano con Lui - dichiarò: ‘L'Ultimo Giorno non verrà finché tutti i musulmani non combatteranno contro gli ebrei, e i musulmani non li uccideranno, e fino a quando gli ebrei si nasconderanno dietro una pietra o un albero, e la pietra o l'albero diranno: O musulmano, o servo di Allah, c'è un ebreo nascosto dietro di me - vieni e uccidilo'".Formatosi nella Prima Intifadah, anche come opposizione interna alla leadership di Arafat, Hamas si è distinto per le sue azioni terroristiche negli anni Novanta, quando si opponeva al processo di pace iniziato con gli accordi di Oslo del 1993. Infatti, Hamas non ha mai accettato alcun piano di pace, né alcuna proposta di partizione per due popoli in due Stati, perché ritiene la Palestina indivisibile per diritto divino: "Il Movimento di Resistenza Islamico crede che la terra di Palestina sia un sacro deposito (waqf), terra islamica affidata alle generazioni dell'islam fino al giorno della resurrezione - leggiamo ancora nello statuto, articolo 11 - Non è accettabile rinunciare ad alcuna parte di essa.

Dans des pays où la législation sur le travail est absente et/ou méconnue des travailleurs, où l'économie informelle est omniprésente, comment garantir la sécurité des travailleurs ? Des tanneurs de Fès au Maroc, aux vendeurs ambulants de Bangui, en République Centrafricaine, en passant par les professionnels camerounais et sénégalais, nous vous proposons de faire un point sur la santé des travailleurs, dans les pays du Sud. Émission délocalisée à Marseille, à l'occasion des « Actualités du Pharo », les rencontres francophones de médecine et de santé publique tropicales, à l'Hôpital de la Timone. Pr Mor Ndiaye, médecin du travail, pneumo-allergologue, médecin expert en Réparation juridique du dommage corporel, chef du service de Médecine du Travail de la Faculté de médecine de l'Université Cheikh Anta Diop de Dakar, Sénégal   Pr Sanae Achour, médecin spécialiste en Toxicologie et responsable du Laboratoire de pharmaco-toxicologie du CHU de Fès, au Maroc, chef de département des Sciences fondamentales de la Faculté de médecine et de pharmacie de Fès, directrice du Laboratoire de recherche biomédicale et translationnelle à l'Université Sidi Mohamed Ben Abdellah (USMBA) et présidente de la Société Marocaine de Toxicologie Clinique et Analytique  Dr Hermione Dahlia Mossoro-Kpinde, médecin du Travail de nationalité centrafricaine, maître-assistant de médecine du Travail à l'Université de Bangui, directrice de la Médecine du travail au ministère du Travail, de l'Emploi, de la Protection Sociale et de la Formation Professionnelle, en Centrafrique Pr Léon Jules Owona Manga, médecin spécialiste de médecine du Travail et maître de conférences agrégé CAMES, enseignant-chercheur et chef de département Santé Publique à la Faculté de Médecine et des Sciences Pharmaceutiques de l'Université de Douala au Cameroun.  Programmation musicale :► Bonga – Kalu Pu► Kanazoé Orkestra – Folikadi. 

Dans des pays où la législation sur le travail est absente et/ou méconnue des travailleurs, où l'économie informelle est omniprésente, comment garantir la sécurité des travailleurs ? Des tanneurs de Fès au Maroc, aux vendeurs ambulants de Bangui, en République Centrafricaine, en passant par les professionnels camerounais et sénégalais, nous vous proposons de faire un point sur la santé des travailleurs, dans les pays du Sud. Émission délocalisée à Marseille, à l'occasion des « Actualités du Pharo », les rencontres francophones de médecine et de santé publique tropicales, à l'Hôpital de la Timone. Pr Mor Ndiaye, médecin du travail, pneumo-allergologue, médecin expert en Réparation juridique du dommage corporel, chef du service de Médecine du Travail de la Faculté de médecine de l'Université Cheikh Anta Diop de Dakar, Sénégal   Pr Sanae Achour, médecin spécialiste en Toxicologie et responsable du Laboratoire de pharmaco-toxicologie du CHU de Fès, au Maroc, chef de département des Sciences fondamentales de la Faculté de médecine et de pharmacie de Fès, directrice du Laboratoire de recherche biomédicale et translationnelle à l'Université Sidi Mohamed Ben Abdellah (USMBA) et présidente de la Société Marocaine de Toxicologie Clinique et Analytique  Dr Hermione Dahlia Mossoro-Kpinde, médecin du Travail de nationalité centrafricaine, maître-assistant de médecine du Travail à l'Université de Bangui, directrice de la Médecine du travail au ministère du Travail, de l'Emploi, de la Protection Sociale et de la Formation Professionnelle, en Centrafrique Pr Léon Jules Owona Manga, médecin spécialiste de médecine du Travail et maître de conférences agrégé CAMES, enseignant-chercheur et chef de département Santé Publique à la Faculté de Médecine et des Sciences Pharmaceutiques de l'Université de Douala au Cameroun.  Programmation musicale :► Bonga – Kalu Pu► Kanazoé Orkestra – Folikadi. 

We're back for Episode 114! In this episode Cody and Eric catch up on the news +  Battle Of The Systems: Itchy And Scratchy In Miniature Golf Madness (Gameboy) vs. Putt and Putter (Game Gear) We are doing news for the first monthly episode and then "catching up" later in the month.   Episode Guide ---------------- 8:48 - Quick Questions 21:12 - Patreon Song 25:55 - Tea Time With Tim - Wii! 44:12 - Eric's Take - Retro Inspired 1:09:22 - News 2:08:04 - Battle Of The Systems: Itchy And Scratchy In Miniature Golf Madness (Gameboy) vs. Putt and Putter (Game Gear) News -     (Tim) - ZX Spectrum Next Issue 2 – Update! - According to the latest Kickstarter update the cases that have been the last piece in the puzzle for final assembly have been signed off and production is about to start at the end of September, this means from that point it could be between 6-8 weeks and then they start to ship. So its looking like we *may* have these in our hands by the November... its only been what.. two years overdue!  https://www.kickstarter.com/projects/spectrumnext/zx-spectrum-next-issue-2/posts/3902386  (Cody) - https://www.worldofretrocomputing.com/2023-worc-expo  (Tim) - One to watch out for coming up – Tokyo Game Show 2023 – during this even in late September will be the “Selected Indie 80” this will be 80 Indie games publishers that will be able to show off their games for free at the show and then enter a completion “SENSE OF WONDER NIGHT 2023” the winner of this event. The top 8 Indie games in this competition will be well worth looking up.   https://events.nikkeibp.co.jp/tgs/2023/en/exhibitor/indie/  (Eric) N64 Core coming soon to MiSTer - https://youtu.be/1CddZmHUzog?si=RkZC_yOxrOvsZ-c9  (Tim) - The game we have all been waiting for finally makes a release. That's right the Snail Maze a hidden game on the original Master System has been extracted from the Master System hardware and ported out to a cartridge by I'm Mike from the Leaded Solder web log. Check out his web log showing just how he managed this:  https://www.leadedsolder.com/2023/08/22/snail-maze-romhack.html  (Cody) August RGN Roundup – UpComing C64 Games  Monty Boyd – Infestation    Yeti Mountain     Funfair Inc  C64 Round Up: August 2023 - We're Back with Exclusive Content  (Eric) - Castle of Shikigami 2 Getting Dreamcast-Inspired Physical Editions For Switch Next Year   https://www.timeextension.com/news/2023/08/castle-of-shikigami-2-getting-dreamcast-inspired-physical-editions-for-switch-next-year  (Cody) Xbox live up to 16.99 per month.   PSN $60 to $80, the Extra plan from $100 to $135, and the Premium plan from $120 to $160.  (Cody) https://www.indieretronews.com/2023/08/atic-atac-remake-classic-utimate-play.html#more  (Eric) - Manic Miner comes to Playdate - https://ramokromok.com/manic-miner-comes-to-playdate  (Eric) - Unofficial Plus/4 Lemmings port is available now - https://ramokromok.com/unofficial-plus-4-lemmings-port-is-available-now  (Cody) https://www.timeextension.com/news/2023/08/new-vectrex-plus-controller-offers-a-cheaper-alternative-to-the-original  (Eric) - Atari 2600+ Pre-Order - https://atari.com/products/atari-2600-plus?fbclid=IwAR2X5Y3sbAVcbFB5WFW844hHlhOe3JHS-ad7leNJk0O88C3TJk3zazDyf8s  (Cody) Atari Releasese new 2600 games.  Outlaw - https://www.timeextension.com/news/2023/09/atari-is-reissuing-outlaw-for-its-legendary-2600-console  Mr Run and Jump https://atari.com/products/mr-run-and-jump-2600-limited-edition    (Eric) - Arcade1Up Announces Atari 50th Anniversary Deluxe Arcade Machine - https://bleedingcool.com/games/arcade1up-announces-atari-50th-anniversary-deluxe-arcade-machine/  (Cody) https://www.timeextension.com/news/2023/09/atari-gobbles-up-atariage-one-of-the-webs-oldest-retro-gaming-sites  (Eric) - Indie Retro News: FIZZ - An innovative platform puzzler for the Commodore 64 by fleischgemuese  https://www.indieretronews.com/2023/09/fizz-innovative-platform-puzzler-for.html?m=1  (Eric) - Sea Of Stars - https://seaofstarsgame.co  (Cody) - https://www.timeextension.com/news/2023/09/portal-64-is-an-incredible-fanmade-demake-in-development-for-the-n64  (Cody) https://www.timeextension.com/news/2023/09/rugrats-is-getting-a-nes-platformer-that-reminds-us-of-bonk  (Cody) https://www.timeextension.com/news/2023/08/msx-reissue-of-compiles-shoot-em-up-zanac-goes-on-pre-sale-in-japan  Please give us a review on Apple Podcasts! Thanks for listening! You can always reach us at podcast@pixelgaiden.com. Send us an email if we missed anything in the show notes you need. You can now support us on Patreon.  Thank you to Henrik Ladefoged, Roy Fielding, Matthew Ackerman, Josh Malone, Daniel James, 10MARC, Eric Sandgren, Brian Arsenault, Retro Gamer Nation, Maciej Sosnowski, Paradroyd, RAM OK ROM OK, Mitsoyama, David Vincent, Ant Stiller, Mr. Toast, Jason Holland, Mark Scott, Vicky Lamburn, Mark Richardson, Scott Partelow, Paul Jacobson, Steve Rasmussen, and Adam from Commodore Chronicles for making this show possible through their generous donation to the show.   Support our sponsor Retro Rewind for all of your Commodore needs! Use our page at https://retrorewind.ca/pixelgaiden and our discount code PG10 for 10%

Greg and Tim have a nice little one one one sit down to answer your questions from over the years. Time Stamp - 00:00:00 - Start 00:02:46 - Housekeeping 00:10:26 - Greg and Tim Holding Down the Fort 00:14:52 - Greg's Box 00:22:19 - Tim's Fitness & Pokemon GO 00:27:12 - Cancer & Birthday Memories 00:42:12 - Weird Things You've Learned from the Internet 00:52:54 - Dinosaurs or Dragons? 00:57:48 - What Commercials are Stuck in Your Head? 01:05:13 - Which Avengers Could Batman Take 1v1? 01:19:33 - Favorite Piece of Clothing? Learn more about your ad choices. Visit megaphone.fm/adchoices

(A brief interlude from the 10 Commandments. I'll be back next week with the eighth commandment.) Hakuna Matata! It means no worries for the rest of your days. At least, that's what Timone and Pumba said in The Lion King. They boldly declared that it was possible to forget all of your worries and live a carefree life. Just ignore the trouble. Don't pay attention to what worries you have. Sure, Simba you may be king soon, but just forget all of that and live with no worries.  If we're honest, that kind of life sounds nice. Wouldn't it be delightful to lay aside all of our worries? Worry surrounds us and even engulfs us at times. Is it even possible? In Matthew 6:25-34, Jesus declares that it is possible. It's possible to live without worry, not because forget our problems but because we trust God with all of our needs. We must remember who our Father is and what our purpose is if we will live a life free from worry.

Today I'm pulling out my therapy hat. Not that I ever have it completely packed away, but today I'm talking to Tim Storey, pop-culture thought-leader, author, speaker, life strategist and counselor. At least that's how he's described in his bio. We talk about labels – including the labels we both have – and the variety of things we do with the goal of helping people. So when he pull out self-help and personal growth gems in today's show, I can't help but contribute my own theories and advice as a therapist. In fact, Tim even lets me anyalyze HIM. And his love life. Good stuff. In the meantime, more background you should know about Tim: One of his first labels was “The Comeback Coach of Beverly Hills.” He coaches and inspires entertainment executives, celebrities, and professional athletes – and their kids. He gives big talks, trains Oprah's staff, hosts The Daily Moment, a series of segments that run on Reach TV at airports and in hotel rooms, he's a pastor, and he's an author, of books like The Miracle Mentality, Comeback & Beyond and  Utmost Living. Tim is also in a new documentary called Anxious Nation, which breaks down how anxiety has overcome so much of our world, especially recently, and especially for teens. It features impressive experts on anxiety, sheds light on how parents often unknowingly teach our kids to feel anxious, and offers practical advice on how to help people with anxiety through it. I hope you walk away from this with a big insight or two. I think you will. And if so, I'd love to hear all about it. You can reach out to me, as always, at rfp@gmail.com or by following me on IG or Facebook at karamayerrobinson.com.   Links to Everything! Subscribe on YouTube for all my interview videos ➤ https://www.youtube.com/channel/UCbR3_S40FqVaWfKhYOTneSQ?sub_confirmation=1 Watch this interview on YouTube ➤  Get 10% your first month of therapy at BetterHelp ➤ betterhelp.com/reallyfamous Get a Really Famous mug ➤ https://really-famous.myspreadshop.com/really+famous-A5d211932162c5f1ba0e0ae33?productType=949&sellable=xrOAqlvEk1UqmOlaDVqJ-949-32&size=29 Shop through my Amazon storefront (hey, thanks!): https://www.amazon.com/shop/reallyfamous Join my special insider's group ➤ http://eepurl.com/dnbUWL Follow me on social media for behind-the-scenes photos and clips of Tim and me ➤  Instagram https://www.instagram.com/karamayerrobinson/  Facebook https://www.facebook.com/karamayerrobinson/  Twitter https://twitter.com/kara1to1  Join our talks in my Facebook Friends and Fans community ➤ https://www.facebook.com/graoups/reallyfamous Check out my sizzle reel ➤ https://really-famous.com/kmr-reel   Celebrity interview by Kara Mayer Robinson Music: Take a Chance by Kevin MacLeod - Incompetech - Creative Commons

Réduire les risques de développer certaines maladies, lutter contre le stress, tonifier son corps et ainsi éviter certaines douleurs… Les bienfaits de l'activité physique pour la santé sont multiples. Alors comment choisir un sport adapté à sa condition physique ? Que faire en cas de blessure ? Les auditeurs de Priorité Santé posent toutes leurs questions à un médecin du sport. Dr Jean-Marc Sène, médecin du Sport à Paris, auteur du livre Le sport : je me lance !, aux éditions In Press.► En fin d'émission, nous retrouvons le Pr Jean Pelletier, neurologue au CHU de la Timone, à Marseille, président du Comité médico-scientifique de la Fondation ARSEP (Fondation pour l'aide à la recherche sur la sclérose en plaques), dans le cadre de la Journée mondiale contre la SEP qui a lieu le 30 mai.

Réduire les risques de développer certaines maladies, lutter contre le stress, tonifier son corps et ainsi éviter certaines douleurs… Les bienfaits de l'activité physique pour la santé sont multiples. Alors comment choisir un sport adapté à sa condition physique ? Que faire en cas de blessure ? Les auditeurs de Priorité Santé posent toutes leurs questions à un médecin du sport. Dr Jean-Marc Sène, médecin du Sport à Paris, auteur du livre Le sport : je me lance !, aux éditions In Press.► En fin d'émission, nous retrouvons le Pr Jean Pelletier, neurologue au CHU de la Timone, à Marseille, président du Comité médico-scientifique de la Fondation ARSEP (Fondation pour l'aide à la recherche sur la sclérose en plaques), dans le cadre de la Journée mondiale contre la SEP qui a lieu le 30 mai.

- Premi il tasto PLAY per ascoltare la catechesi del giorno e condividi con altri se vuoi -+ Dagli Atti degli Apostoli +In quei giorni, aumentando il numero dei discepoli, quelli di lingua greca mormorarono contro quelli di lingua ebraica perché, nell'assistenza quotidiana, venivano trascurate le loro vedove.Allora i Dodici convocarono il gruppo dei discepoli e dissero: «Non è giusto che noi lasciamo da parte la parola di Dio per servire alle mense. Dunque, fratelli, cercate fra voi sette uomini di buona reputazione, pieni di Spirito e di sapienza, ai quali affideremo questo incarico. Noi, invece, ci dedicheremo alla preghiera e al servizio della Parola».Piacque questa proposta a tutto il gruppo e scelsero Stefano, uomo pieno di fede e di Spirito Santo, Filippo, Pròcoro, Nicànore, Timone, Parmenàs e Nicola, un prosèlito di Antiòchia. Li presentarono agli apostoli e, dopo aver pregato, imposero loro le mani.E la parola di Dio si diffondeva e il numero dei discepoli a Gerusalemme si moltiplicava grandemente; anche una grande moltitudine di sacerdoti aderiva alla fede.Parola del Signore.

Like so many, Tim had a crazy year from 2020 through 2022. In years to follow he went through experiences that no person would wish to have. Listen to how God works through Tim's life! This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit wellsaidpodcast.substack.com

Jeff Buckley goes on the record about:His childhoodHis voiceGrace the conceptGrace the albumRap.Plus:His mother talks about when Jeff met his father, TimOne of his major influences speaks about Buckley the singer.

Tra i membri degli oltre 100 equipaggi in gara, il velista Corrado Rossignoli sarà a bordo dell'unica barca con immatricolazione italiana con il ruolo di prodiere.

For today's perspective, Timone reminds us that the power of choice is within us and we cannot allow our circumstances or situations to limit that power. --- Support this podcast: https://anchor.fm/cl531/support

L'équipe de Priorité santé est à Marseille, à l'occasion des Actualités du Pharo, rendez-vous donné par le Groupe d'intervention en santé publique et épidémiologie. Pour cette première émission, nous parlons de la gestion des crises sanitaires : quelle est la place des systèmes d'information dans l'alerte et la réponse aux crises ? Approche historique et perspective d'avenir, dans le sillage de la crise du Covid-19 ? Émission délocalisée à Marseille, à l'occasion des « XXVIIe Actualités du Pharo », les rencontres francophones de médecine et de santé publique tropicales, à l'Hôpital de la Timone. Cette année, le thème est : « Alerte et réponse face aux crises sanitaires : place des systèmes d'information ». Quel a été l'impact de la pandémie sur les dispositifs de veille sanitaire ? Quelles possibilités les nouvelles technologies offrent-elles en matière de transmission des données ? Comment la surveillance s'opère-t-elle, en cas d'événements sanitaires, au niveau communautaire exclusif ? Pr Antoine Flahault, épidémiologiste, professeur de Santé publique à l'Université de Genève et directeur de l'Institut de santé globale à la Faculté de Médecine de l'Université de Genève Dr Ousmane Ly, médecin et expert international en Santé numérique, enseignant chercheur à l'Université des Sciences techniques et technologiques de Bamako, et professionnel de recherche au CIDIS de l'Université de Sherbrooke du Canada Pr Anne-Marie Moulin, médecin, spécialiste de Santé tropicale, philosophe et directeur de recherche émérite au CNRS. Livre à paraître sur le Covid-19 L'épidémie par qui le scandale arrive.  

L'équipe de Priorité santé est à Marseille, à l'occasion des Actualités du Pharo, rendez-vous donné par le Groupe d'intervention en santé publique et épidémiologie. Dans cette deuxième émission, nous abordons l'actualité des maladies émergentes et des zoonoses : alerte aux fièvres hémorragiques en Afrique de l'Ouest et en Afrique centrale, état des lieux sur l'épidémie de variole du singe, résurgence périodique des épidémies de peste à Madagascar. Émission délocalisée à Marseille, à l'occasion des « XXVIIe Actualités du Pharo », les rencontres francophones de médecine et de santé publique tropicales, à l'Hôpital de la Timone. Cette année, le thème est : « Alerte et réponse face aux crises sanitaires : place des systèmes d'information ». L'actualité de l'émergence place au premier plan le concept ONE HEALTH/une seule santé : cette approche systémique de la santé, qui intègre santé publique/animale et environnementale. Pr Christophe Rapp, infectiologue à l'Hôpital américain de Paris à Neuilly, en région parisienne Dr Odile Ouwe Missi Oukem, immunologiste et représentante de la Fondation Mérieux au Mali Dr Mamy Randria, médecin infectiologue et chef du service des Maladies infectieuses et tropicales au Centre hospitalier universitaire Joseph Raseta de Befelatanana à Antananarivo, Madagascar. 

L'équipe de Priorité santé est à Marseille, à l'occasion des Actualités du Pharo, rendez-vous donné par le Groupe d'intervention en santé publique et épidémiologie. Pour cette première émission, nous parlons de la gestion des crises sanitaires : quelle est la place des systèmes d'information dans l'alerte et la réponse aux crises ? Approche historique et perspective d'avenir, dans le sillage de la crise du Covid-19 ? Émission délocalisée à Marseille, à l'occasion des « XXVIIe Actualités du Pharo », les rencontres francophones de médecine et de santé publique tropicales, à l'Hôpital de la Timone. Cette année, le thème est : « Alerte et réponse face aux crises sanitaires : place des systèmes d'information ». Quel a été l'impact de la pandémie sur les dispositifs de veille sanitaire ? Quelles possibilités les nouvelles technologies offrent-elles en matière de transmission des données ? Comment la surveillance s'opère-t-elle, en cas d'événements sanitaires, au niveau communautaire exclusif ? Pr Antoine Flahault, épidémiologiste, professeur de Santé publique à l'Université de Genève et directeur de l'Institut de santé globale à la Faculté de Médecine de l'Université de Genève Dr Ousmane Ly, médecin et expert international en Santé numérique, enseignant chercheur à l'Université des Sciences techniques et technologiques de Bamako, et professionnel de recherche au CIDIS de l'Université de Sherbrooke du Canada Pr Anne-Marie Moulin, médecin, spécialiste de Santé tropicale, philosophe et directeur de recherche émérite au CNRS. Livre à paraître sur le Covid-19 L'épidémie par qui le scandale arrive.  

L'équipe de Priorité santé est à Marseille, à l'occasion des Actualités du Pharo, rendez-vous donné par le Groupe d'intervention en santé publique et épidémiologie. Dans cette deuxième émission, nous abordons l'actualité des maladies émergentes et des zoonoses : alerte aux fièvres hémorragiques en Afrique de l'Ouest et en Afrique centrale, état des lieux sur l'épidémie de variole du singe, résurgence périodique des épidémies de peste à Madagascar. Émission délocalisée à Marseille, à l'occasion des « XXVIIe Actualités du Pharo », les rencontres francophones de médecine et de santé publique tropicales, à l'Hôpital de la Timone. Cette année, le thème est : « Alerte et réponse face aux crises sanitaires : place des systèmes d'information ». L'actualité de l'émergence place au premier plan le concept ONE HEALTH/une seule santé : cette approche systémique de la santé, qui intègre santé publique/animale et environnementale. Pr Christophe Rapp, infectiologue à l'Hôpital américain de Paris à Neuilly, en région parisienne Dr Odile Ouwe Missi Oukem, immunologiste et représentante de la Fondation Mérieux au Mali Dr Mamy Randria, médecin infectiologue et chef du service des Maladies infectieuses et tropicales au Centre hospitalier universitaire Joseph Raseta de Befelatanana à Antananarivo, Madagascar. 

Qu'est-ce que la crise de la pandémie de Covid-19 nous a appris en matière d'alerte sanitaire ?  Pr Antoine Flahault, épidémiologiste, professeur de santé publique à l'université de Genève et directeur de l'Institut de santé globale à la faculté de médecine de l'université de Genève Retrouvez l'émission intégrale en cliquant ici.    Émission délocalisée à Marseille, à l'occasion des « XXVIIe Actualités du Pharo », les rencontres francophones de médecine et de santé publique tropicales, à l'hôpital de la Timone. Cette année le thème est : « Alerte et réponse face aux crises sanitaires : place des systèmes d'information ».

Endémie, épidémie, pandémie : quelles sont les différences entre ces trois situations sanitaires ? Comment se prémunir des grandes épidémies ?  Dr Odile Ouwe Missi Oukem, immunologiste et représentante de la Fondation Mérieux au Mali Émission délocalisée à Marseille, à l'occasion des « XXVIIe Actualités du Pharo », les rencontres francophones de médecine et de santé publique tropicales, à l'hôpital de la Timone. Cette année, le thème est : « Alerte et réponse face aux crises sanitaires : place des systèmes d'information ». Retrouvez l'émission intégrale en cliquant ici.

Preaching for the Twenty-third Sunday in Ordinary Time, timone davis offers a reflection on becoming "bluetooth Christians": "My call to live in Christ is not my parent's call, not my siblings' call, not my friends' call. It is MY call. And as such, I must move past what anyone else may think or say, hoist up my cross, and follow Christ." timone davis* is a cradle Catholic who was a “pewster” until she discovered that the uselessness of the Church was because she wasn't giving anything of herself. After committing to do something, her life changed. Her first ministry was with the RCIA, where she not only welcomed others into the Church, but also revitalized her own spirituality. After working for the Archdiocese of Chicago as the coordinator of ReCiL – Reclaiming Christ in Life Young Adult Ministry, timone launched PEACE centered WHOLENESS with her husband Orlando, where they are blending clinical counseling and spiritual companioning. In addition to running a business, timone is an assistant professor in the Institute of Pastoral Studies at Loyola University Chicago. In her spare time, she serves as the treasurer of the National Institute for Ministry with Young Adults and Associate Convener of the Black Catholic Theological Symposium. *dr. timone davis uses lower case letters in the spelling of her name to indicate her willingness to embody the creedal assertion in John 3:30 in her everyday living.

About TimTim's tech career spans over 20 years through various sectors. Tim's initial journey into tech started as a US Marine. Later, he left government contracting for the private sector, working both in large corporate environments and in small startups. While working in the private sector, he honed his skills in systems administration and operations for large Unix-based datastores.Today, Tim leverages his years in operations, DevOps, and Site Reliability Engineering to advise and consult with clients in his current role. Tim is also a father of five children, as well as a competitive Brazilian Jiu-Jitsu practitioner. Currently, he is the reigning American National and 3-time Pan American Brazilian Jiu-Jitsu champion in his division.Links Referenced:Twitter: https://twitter.com/elchefe TranscriptAnnouncer: Hello, and welcome to Screaming in the Cloud with your host, Chief Cloud Economist at The Duckbill Group, Corey Quinn. This weekly show features conversations with people doing interesting work in the world of cloud, thoughtful commentary on the state of the technical world, and ridiculous titles for which Corey refuses to apologize. This is Screaming in the Cloud.Corey: This episode is sponsored in part by Honeycomb. When production is running slow, it's hard to know where problems originate. Is it your application code, users, or the underlying systems? I've got five bucks on DNS, personally. Why scroll through endless dashboards while dealing with alert floods, going from tool to tool to tool that you employ, guessing at which puzzle pieces matter? Context switching and tool sprawl are slowly killing both your team and your business. You should care more about one of those than the other; which one is up to you. Drop the separate pillars and enter a world of getting one unified understanding of the one thing driving your business: production. With Honeycomb, you guess less and know more. Try it for free at honeycomb.io/screaminginthecloud. Observability: it's more than just hipster monitoring.Corey: I come bearing ill tidings. Developers are responsible for more than ever these days. Not just the code that they write, but also the containers and the cloud infrastructure that their apps run on. Because serverless means it's still somebody's problem. And a big part of that responsibility is app security from code to cloud. And that's where our friend Snyk comes in. Snyk is a frictionless security platform that meets developers where they are - Finding and fixing vulnerabilities right from the CLI, IDEs, Repos, and Pipelines. Snyk integrates seamlessly with AWS offerings like code pipeline, EKS, ECR, and more! As well as things you're actually likely to be using. Deploy on AWS, secure with Snyk. Learn more at Snyk.co/scream That's S-N-Y-K.co/screamCorey: Welcome to Screaming in the Cloud. I'm Corey Quinn. A bit of a sad episode Today. I am joined by Duckbill Group principal cloud economist, Tim Banks, but by the time this publishes, he will have left the Duckbill nest, as it were. Tim, thank you for joining me, and can I just start by saying, this is sad?Tim: It is. I have really enjoyed being with Duckbill and I will never forget that message you sent me. It's like, “Hey, would you like to do this?” And I was like, “Boy would I.” It's been a fantastic ride and I have enjoyed working with a friend. And I'm glad that we remain friends to this day and always will be, so far as I can tell.Corey: Yes, yes. What you can't see while recording this, I'm actually sitting in the same room as Tim with a weapon pointed at him to make sure that he stays exactly on message. Yeah, I kid. There's been a lot that's happened over the last year. We only got to spend time together in person once at re:Invent. I think because re:Invent is such a blur for me, I don't remember who the hell I talk to.Someone can walk up and say, “Oh yeah, we met at re:Invent,” and I'll nod and say, “Oh yeah,” and I will have no recollection of that whatsoever. But you don't argue with people. But I do distinctly remember hanging out with you there. But since then, it's been a purely distributed company, purely distributed work.Tim: Yeah, that's the only time I've seen you since I've worked here. It's the only time I met Mike. But it's weird because it's like, someone you work with you see every day virtually and talk to, and then you actually get to, like, IRL them and like, “Oh, wow. I had all these, kind of, conceptions of, you know, what you are or who you are as a person, and then you get to, like, check yourself. Was I right? Was I wrong?” I was like, “Oh, you're taller than I thought; you're shorter than I thought,” you know, whatever it was.But I think the fun part about it was we all end up being so close by the nature of how we work that it was just like going back and seeing family after a while; you already know who they are and how they are and about them. So, it felt good, but it felt familiar. That's a great feeling to have. To me, that's a sign of a very successful distributed culture.Corey: Yeah, it's weird the kinds of friendships we've built during the pandemic. When I was in New York for the summit, I got to meet Linda Haviv at AWS for the first time, despite spending the past year or so talking to her repeatedly. As I referred to her the entire time I was in New York, this is Linda, my new old friend because that is exactly how it felt. It's the idea of meeting someone in person that you've had a long-term ongoing friendship with. It's just a really—it's a strange way Everything's new but it's not, all at the same time.It reminds me of the early days of the internet culture where I had more friends online than off, which in my case was not hard. And finally meeting them, some people were exactly like they were described and others were nothing at all like they presented. Now that we have Zoom and this constant level of Slack chatter and whatnot, it's become a lot easier to get a read on what someone is like, I think.Tim: I think so too, you know, we've gotten away—and I think largely because of the pandemic—of just talking about work at work, right? The idea of embracing, you know, almost a cliche of the whole person. But it's become a very necessary thing as people have dealt with pandemic, social upheaval, political climates, and whatever, while they're working from home. You can't compartmentalize that safely in perpetuity, right? So, you do end up getting to know people very well, especially in what their concerns are, what their anxieties are, what makes them happy, what makes them sad, things that go on in their lives.You bring all that to your distributed culture because it's not like you leave it at the door, when you walk out. You're not walking out anymore; you're walking to another room, and it's hard to walk away from those things in this day and age. And we shouldn't have to, right? I feel like for a successful and nurturing culture—whatever it is, whether it's tech culture, whether it's whatever kind of work culture—you can't say, “I only want your productivity and nothing else about you,” and expect people to sustain that. So, you see these companies are, like, you know, “We don't have political discussions. We don't have personal discussions. We're just about the work.” I'm like, “All right, well, that's not going to last.” A person cannot just be an automaton in perpetuity and expect them to grow and thrive.Corey: And this is why you're leaving. And I want to give that a little context because without, sounds absolutely freaking horrifying. You've been a strong advocate for an awful lot of bringing the human to work, on your philosophy around leadership, around management. And you've often been acting in that capacity throughout, I would say, the majority of your career. But here at The Duckbill Group, we don't have a scale of team where you being the director of the team or leader of the team is going to happen in anything approaching the near or mid-term.And so, much of your philosophy is great and all because it's easy to sit here at a small company and start talking about, “Oh, this is how you should be doing it.” You have the opportunity to wind up making a much deeper impact on a lot more people from a management perspective, but you do in fact, need a team to manage as opposed to sitting around there, “Oh, yeah. Who do you manage?” “This one person and I'm doing all of these things to make their life and job awesome.” It's like, “Yeah, how many hours a week are you spending in one-on-ones?” “20 to 25.”Okay, maybe you need a slightly larger team so you can diffuse that out a little bit. And we are definitely sad to be losing you; super excited to see where you wind up going next. This has been a long time coming where there are things that you have absolutely knocked out of the park here at The Duckbill Group, but you also have that growing—from what I picked up on anyway—need to set a good management example. And lord knows this industry needs more of those. So first, sad to lose you. Secondly, very excited for where you wind up next and what they're in for, even though it has a strong likelihood that they don't know the half of it yet.Tim: One of the things that I like about The Duckbill Group and how my time here has been is the first thing that I was asked in the interview was very sincere, like, “Well, what's your next job?” And I was very clear. It's like, “After this, I want to be a director or VP of engineering because I would like to be a force multiplier, right?” I would like to make engineering orgs better. I would like to make engineering practices better. I want to make the engineers better, right?And not by driving KPIs and not by management, right, not administrative functions. I want to do it via leadership. I want to do it by setting examples, making safe places for people, making people feel like they're important and invested in, nurturing them, right? I've said this before I—this analogy was getting me somewhere else and I love, it's like, if I plant a tree and I want it to grow apples, right, I'm not going to sit there and put a number down of apples it's expected to produce, and then put it on a performance plan if it doesn't get that number of apples, right? I need to nurture the tree, I need to fertilize it, I need to protect it, I need to keep it safe, I need to keep it safe from the elements, I need to make sure that it doesn't have parasites, I need to take care of that tree.And if that tree grows and it's healthy and it's thriving, it will produce, right? But I'm not—I can't just expect apples if I'm not taking care of the tree. Now, people are not trees, but you still have to take care of the people if you want them to do things. And if you can't take care of the people, if you can't manage the environment that they're in to make it safe, if you can't give them the things they need to be successful, then you're just going to be holding numbers over someone and expecting to hit them.And that doesn't work. That's not something that's sustainable. And it doesn't really—it's not even about how much you pay them. You must pay them well, right, but it has to be more than just that if you want people to succeed. And that doesn't necessarily mean—like, one thing is at the Duckbill Group I love, succeeding doesn't necessarily mean that I'm going to stay at—or your engineer is going to stay at one place in perpetuity. If you mentor and train and coach and give an engineer opportunity to grow and thrive and what they do is they go to another job for a title increase and a pay increase or something like that, you did your job.Corey: A lot of companies love to tell that lie and they almost convince themselves of it where I look at your resume, and great you have not generally crossed the two-year mark at companies for the last decade. I never did until I started at this place. But we magically always liked to pretend in job interviews that, “Oh yeah, this is my forever job—” like you're a rescue dog getting adopted or something, “—and I'm going to work here for 25 years and get a gold watch and a pension at the end of it.” It's lunacy. I have never seen the value in lying to ourselves like that, which is why we start our interviews with, “What's the job after this and how do we help you get there?”It's important that we ask those questions and acknowledge that reality. And the downside to it—if you can call it a downside—is you've got to live by it. It's not just words, you can slop onto an interview questionnaire; you actually have to mean it. People can see through insincerity.Tim: And it's one of the things, like, if you run an org and you grow your people and you don't have a place for them to grow into, you should expect and encourage them to find those opportunities elsewhere. It is not reasonable, I feel like, as a leader for you expect people to stay in a place where they have grown past or grown out of. You need to either need to give them a new pot to grow into or you need to let them move elsewhere and thrive and grow. And moving elsewhere—like, if you have a retention problem where you can't retain anybody, that's a problem, but if you have your junior engineers who become senior engineers at other places, right, and everyone leaves on good terms, and they got the role and you gave them a great recommendation and they give glowing recommendations to you, there's nothing wrong with that. That's not a failure; that's success.Corey: One bit of I would say pushback that I suspect you might get when talking to people about what's next is that, “Well, you are just a consultant, on some level, for a year.” You always know that someone is really arguing in good faith when they describe what you did with the word ‘just,' but we'll skip past that part. And it's, “You're just a consultant. What would you possibly know about team management and team dynamics?” And there is a little bit of truth to that insofar as the worst place in the world to get management advice is very clearly on Twitter.It turns out that most interpersonal scenarios are, one, far too personal to wind up tweeting about, and two, do not lend themselves to easy solutions that succinctly fit within 280 characters. Imagine that. The counter-argument though, is that you have—correctly from where I sit—identified a number of recurring dynamics on teams that you have encountered and worked with deeply as a large number of engagements. And these are recurring things, I want to be clear. So, I'm not talking about one particular client. If you're one of our clients and listen to this thinking that we're somehow subtweeting you with our voices—I don't know what that is; subwoofing, maybe?Tim: [crosstalk 00:12:05]—Corey: Is that what a subwoofer is? I'm not an audio person.Tim: Throwing shade, we'll just say—call it throwing shade.Corey: Yeah, we're not throwing shade at any one person, team, or group in particular; these are recurring things. Tim, what have you seen?Tim: And so, I think the biggest thing I see is folks that are on the precipice of a big technological change, right, and there is an extraordinary amount of anxiety, right? I've seen a number of customers through our engagements that, “We are moving away from this legacy platform,” or from this thing that we have been doing for X amount of time. And everyone has staked the other domains, staked out their areas of expertise and control and we're going to change that. And the solution to that is not a technical solution. You don't fix that by Helm charts, or Terraform, or CloudFormation. You fix that by conversations, and you fix that by listening. You fix that by finding ways to reassure folks and giving them confidence in their ability to adjust and thrive in a new environment.If you take somebody who's been, you know, an Oracle admin for 20 years, and you going to say, “Great. Now, you're going to learn, you're going to do this an RDS,” that's a whole new animal, and folks feel like, well, you know, I can't learn something new like that? Well, yeah you can. If you can learn Oracle, you can learn anything. I firmly believe that.But that's one of the conversations we have, it's never, almost never a technical problem folks have. We need to reassure people, right? And so, folks who reach out to us, it's typically folks who are trying to get their organizations in that direction. Another thing we see sometimes is that we find that there's a disconnect between leadership and the engineers. They have either different priorities or different understandings of what's going on. And we come in to solve a problem, which may be cost but that's not the problem we actually solve. The problem we actually solve is fixing this communication bridges between management and leadership.And that's almost an every time occurred. At some point or another, there's some disconnect there. And that's the best part of the job. Like, the reason I do this consulting gig is not because I want to bang away at code. If I've had to do that, that's an anomaly for sure because I want to have these conversations.And people want to have these conversations; they want to get these problems solved and sometimes they don't know how to. And that is the common thing, I think, through all of our customers. Like, we need some amount of expertise to help us find solutions to these things that aren't necessarily technical problems. And I think that's where we run into problems as an industry, right, where we think a lot of things are technical problems or have technical solutions, and they don't. There are people problems. They're—Corey: Here at The Duckbill Group, we're basically marriage counseling for engineering and finance in many cases.Tim: We really are.Corey: This is why were people not software.Tim: Yeah. And I will say this very firmly and you can quote me on this: like, you cannot replace us. You cannot replace the kind of engagements we do with software. You can't. Can't be done, right? Software is not empathetic.Corey: There are a whole series of questions we ask our clients at the start of an engagement and the answers to those questions change what we ask them going forward. In fact, even the level-setting in the conversation that we have at the start of that changes the nature of those. We're not reading from a list; we're trying to build an understanding. There is a process around what we do, but it's not process that can ever be scoped down to the point where it's just a list of questions or a questionnaire that isn't maddening for people to fill out because it's so deeply and clearly misses the mark around context of what they're actually doing.Tim: Mm-hm. Our engaged with their conversations. That's all they are. They're really in-depth conversations where we're going to start asking questions and we're going to ask questions about those answers. We're start pulling out strings and kicking over rocks and seeing what we find.And that's the kind of thing that, you know, you would expect anyone to do who's coming in and saying, “Okay, we have a problem. Now, let's figure it out.” Right? Well, you can't just look at something on the surface, and say, “Oh, I know what this is.” Right? You know, for someone to say, “Oh, I know how to fix this,” when they walk in is the surest way to know that someone doesn't know what they're talking about, right?Corey: Oh, easiest thing in the world is to walk in and say, “This is broken and wrong.” That can translate directly to, “Hi, I am very junior. Please feed my own ass to me.” Because no one shows up at work thinking they're going to do a crap job today on purpose. There's a reason things are the way that they are.Tim: Mm-hm. And that's the biggest piece of context we get from our customers is we can understand what the best practices are. You can go Google them right now and say, “This is the ten things you're supposed to do all the time,” right? And we would be really, really crappy consultants if we just read off that list, right? We need to have context: does this thing make sense? Is this the best practice? Maybe, but we want to know why you did it this way.And after you tell us that way, I'm like, “You know what? I would do it the exact same way for this use case.” And that's great. We can say like, “This is the best way to do that. Good job.” It's atypical; it's unusual, but it solves the problems that you need solving.And that's where I think a lot of people miss. Like, you know, you can go—and not to throw shade at AWS's Trusted Advisor, but we're going to throw shade at AWS's Trusted Advisor—and the fact that it will give you—Corey: It is Plausible Advisor at absolute best.Tim: [laugh]. It will give you suggestions that have no context. And a lot of the automated AI things that will recommend that you do this and this and this and this are pretty much all the same. And they have no context because they don't understand what you're trying to do. And that's what makes the difference between people. There's these people problems.And so, one of the things that I think is really interesting is that we have moved into doing a shorter engagement style that is very short. It's very quick, it's very kind of almost tactical, but we go in, we look at your bill, we ask you some questions, and we're going to give you a list of suggestions that are going to save you a significant amount of money right away, right? So, a lot of times, folks when they need quick wins, or they don't really need us to deep-dive into all their DynamoDB access patterns, right? They just want like, “Hey, what are the five things we can do to save us some money?” And we're like, “Well, here they are. And here's what we think they're going to save you.” And folks who really enjoyed that type of engagement. And it's one of my favorite ones to do.Corey: This episode is sponsored in part by LaunchDarkly. Take a look at what it takes to get your code into production. I'm going to just guess that it's awful because it's always awful. No one loves their deployment process. What if launching new features didn't require you to do a full-on code and possibly infrastructure deploy? What if you could test on a small subset of users and then roll it back immediately if results aren't what you expect? LaunchDarkly does exactly this. To learn more, visit launchdarkly.com and tell them Corey sent you, and watch for the wince.Corey: I can also predict that people are going to have questions for you—probably inane—of, well, you were a consultant, how are your actual technical chops? And I love answering these questions with data. So, I have here pulled up the last six months of The Duckbill Group's AWS bills. And for those who are unaware, every cloud economist has their own dedicated test account for testing out strange things that we come across. And again, can the correct answer in many consulting engagements is, “I don't know, but I'll find out.”Well, this is how we find out. We run tests and learn these things ourselves. I suppose we could extend this benefit, if you want to call it that, to people who aren't cloud economists but I'm not entirely sure what, I don't know, an audio engineer is going to do with an AWS account that isn't, you know, kind of horrifying. To the audio engineer that is editing this podcast, my condolences if you take that as a slight, and if there is something you would use an AWS account for, please let me know. We'll come talk about it here.But back to topic, looking at the last six months of your bill for your account—that's right, a ritualistic shaming of the AWS bill—in January you spent $16.06. In February, you spent 44 cents. And you realized that was too high, so back in March, you then spent 19 cents. And then $3.01 back in April. May wound up $10.02, and now you're $9.84 as of June. July has not yet finalized as of this recording.And what I want to highlight—and what that tells me when I look at these types of bills—and I assure you as the world's leading self-described expert in AWS billing, I'm right; listening to me is a best practice on these things—that shows the exact opposite of a steady-state workload. There's a lot of dynamism to those giant swings because we don't have cloud economists who are going to just run these things steady-state for the rest of our lives. Those are experiments of building and testing out new and exciting things in a whole bunch of very weird, very strange ways. Whenever I wind up talking to someone in one of the overarching AWS services at AWS and I pull up my account, a common refrain is, “Wow, you use an awful lot of services.” Right. I'm not just sitting here run and EC2 instances forever. Imagine that. And your account is a perfect microcosm of that entire philosophy.Tim: Well, I don't know all the answers, right? And I will never profess all the answers. And before I say, “You should do this—” or maybe I will say, “You might be able to do this. Let me go save as possible.” [laugh]. Right? And so, just let me just see, can you do this? Does this work? No, I guess it doesn't. Or AWS docu—especially, “The AWS documentation says this. Let me see if that's actually the case.”Corey: I don't believe that they intend to lie, but—Tim: No.Corey: —they also certainly don't get it correct all the time.Tim: And to be fair, they have, what, 728 services by this point, and that's a lot of documentation you're not going to get—Corey: Three more have launched since the start of this recording.Tim: I—yeah, actually—well, by the time this hits, they're probably going to have 22. But we'll [laugh] see. But yeah, no. And that's fine. And they're not going to have every use case, and every edge, kind of like, concern handled, and so that's why we need to kick the tires a little bit.And what I think more than anything else is, you know, sometimes we just do things out of convenience. Like, “Well, I don't want to run this on this; let me just fire it up because it's not my money.” [laugh]. But we also want to be fairly concerned about you know, how we do things. You don't want to run a fleet of z1ds, obviously.But there is a certain amount of tire-kicking and infrastructure spinning up that you have to do in order to maintain freshness, right? And it's not a thing where I'm going to say, “Oh, I know YAML off the top of my head, and I need to do—you know, I'm up to speed on every single possible API call that you can make.” No. My technical prowess has always been in architecture and operations. So, I think when we have these conversations, folks mostly tend to be impressed by not only business acumen and strategy, but also being able to get down to the weeds and talking with the developers and the engineers about the minutia. And you will have seen you know, the feedback that I've gotten about my technical prowess has always been good. You know, I can hang with anybody, I feel like.Corey: I would agree wholeheartedly. It's been really interesting watching you in conversations, internally and with our clients, where you will just idly bust out something fricking brilliant out of left field. And most of the time, I don't think you even realize it. It's just one of those things that makes intuitive and instinctive sense to you. And you basically just leave people stunned and their scribbling notes and trying to wrap their heads around what you just said.And it's adorable because sometimes you wind up almost, like, looking embarrassed, like, “Did I say something rude and not realize it? Like, I wasn't trying to be insulting.” It's like, “Nope, nope. You're just doing your thing, Tim. Just keep on doing it. That's fine.”Tim: Yeah, it's funny because, like you, one of the things that I've really enjoyed about it is, like, we'll just start bouncing ideas off of each other and come up with something brilliant. “Yeah, let's do that.” And then, “Okay, this is now a thing.” And it's like, you know, there's something to be said about being around smart people. So, it's not just me coming up with something brilliant; these are almost always fruits of a conversation and discussion being had, and then you formulate something great in your head.But again, this is why I love the aspect of talking and having conversations with people, so that way you can come up with something kind of brilliant. None of this is done in a silo. Like we're not really, really good at what we do because we don't rely or talk to or have conversations with other people.Corey: One thing that you did that I think is one of the most transformative things that has happened in company history in some respects has been when you started, and for the first half of your tenure here, we had two engagement types that we would wind up giving our consulting clients. There's contract negotiation, where we help companies negotiate their long-term commitment contracts with AWS—and we're effective at it and that's fun; that's basically what you would more or less expected to be—and the other is our cost optimization project engagements. And those tend to look six to eight weeks where we wind up going in deep-dives into the intricacies of an organization's AWS accounts, bills, strategy, growth plan, et cetera, et cetera, et cetera, to an exhaustive level of detail. And in an interest of being probably overly transparent here, I didn't like working on those engagements myself. I like coming in, finding the big things that will be transformative to reduce the bills—it's like solving a puzzle—and then the relatively in-depth analysis for things that are a relatively paltry portion of the AWS bill does not really lead me to enjoying the work very much.And I beat my head against that one for years. And you busted out one day with an idea that became our third type of engagement, which is the first pass, where we charge significantly less for the engagement and it essentially distills down into you get us to talk to your engineering teams for a day. Bring us any questions, give us access in advance to these things, and we will basically go on a whirlwind guided tour and lay waste to your AWS bill and highlight different opportunities that we see to optimize these things. And it has been an absolute smash success. People love the engagements.Very often, it leads to that second full-bore engagement that I was describing earlier, but it also aligns very well with the way that I like to think about these things. I'm a great consultant, specifically because once I've delivered the value, I like to leave. Whereas as an employee, I just sort of linger around, and then I go cause problems and other people's departments—ideally, not on purpose, but you know, I am me—and this really emphasizes that and keeps me moving quickly. I really, really like that engagement style and I have you to thank for coming up with the idea and finding a way to do it that didn't either not resonate with the market—in which case, we're not selling a damn thing—or wound up completely eviscerating the value of the longer-term deep-dive engagements, and you threaded that needle perfectly.Tim: I thank you; I appreciate that. There was this kind of vacuum that I saw where, both from a cost and from a resource point where six to eight weeks is a long time for an engineering org to dedicate to any one thing, especially if that one thing isn't directly making money. But engineering orgs are also very interested in saving money. But it's especially in smaller orgs where that velocity is very important, they don't have six to eight weeks for that. They can't dedicate the resources to those deep-dives all the time, and all the conversations we—and when we do a COP, it is exhaustive. We are exploring every avenue to almost an absurd level, right?And that's not the right engagement for a lot of orgs, right? So, coming in and saying, “Hey, you know, this is a quick one; these are the things that you can do. This is 90% of the savings you're going to realize. These things: bam, bam, bam, bam, bam.” Right?And then we give it to the folks and we let them work on it, and then they're like, “Hey, we need this because we want to negotiate EDP,” or, “We need this because, you know, we're just trying to make sure that our costs are in line so we can be more agile, so we can do this project, or whatever.” Right? And then there are a lot of other orgs that do need that exhaustive kind of thing, larger orgs especially, right? Larger, more complex orgs, orgs that are trying to maybe—like, if you're trying to make a play to get acquired, you want to get this very, very in-depth study so you know all your liabilities and all your assets, so that way you can fix those problems and make it very attractive for someone to buy you, right? Or orgs that just have, like, we are not having an impending EDP; we have a lot of time to be able to focus on these things, and we can build this into the roadmap, right?Then we can do a very exhaustive study of those things. But for a lot of times, people are just like, “Look, I just need to save X amount of money on my AWS bill and can you do that?” Well, sure. We can go in there and have those conversations and give you a lot of savings. And I'm very much in the camp of, you know, ‘perfect is the enemy of good.' I don't have to save down to the nth penny on your DynamoDB bill. But if I can, shave—cut it in half, that's great. Most people are very happy about those kinds of things. And that's a very routine finding for us.Corey: One other aspect that I really liked about it, too, is that it let us move down market a bit, away from companies that are spending millions of dollars a month. Because yeah, the ROI for those customers is a slam dunk on virtually any engagement that we could put together, but what about the smaller companies, the ones that are not spending that much money, yet? They've never felt great talk to them and say, “Oh, just go screw up your AWS bill some more. Then, then you will absolutely be able to generate some value. Maybe turn off MFA and post your credentials to GitHub or something. That'll speed up the process nicely.”That's terrible advice and we can't do it. But this enables us to move down to smaller companies that are earlier in their cloud estate build-out or are growing organically rather than trying to do a giant migration as sort of greenfield growth approach. I really, really like our ability to help companies that are a bit earlier in their cloud journey, as well as in smaller environments, just because I guess, on some level, for me, at least, when you see enormous multimillion-dollar levels of spend, the misconfigurations are generally less fun to find; they're less exciting. Because, yeah at a small scale, you can screw up and your Managed NAT Gateway bill is a third of your spend. When you're spending $80 million a year, you're not wasting that kind of money on Managed NAT Gateways because that misconfiguration becomes visible from frickin' orbit.So, someone has already found that stuff. And it's always then it's almost certainly EC2, RDS, and storage. Great. Then there's some weird data transfer stuff and it starts to look a lot more identical. Smaller accounts, at least from my perspective, tend to have a lot more of interesting things to learn hiding in the shadows.Tim: Oh, absolutely. And I think the impact that you make for the future for small companies much higher, right? You go in there and you have an engagement, you can say, “Okay, I understand the business reason why you did this here, but if you make these changes—bam, bam, bam—12 to 18 months and on, right, this is going to make a huge difference in your business. You're going to save a tremendous amount of money and you're going to be much more agile.”You did this thing because it worked for the POC, it worked for the MVP, right? That's great, but before it gets too big and becomes load-bearing technical debt, let's make some changes to put you in a better position, both for cost optimization and an architectural future that you don't have to then break a bone that's already set to try and fix it. So, getting in there before there's a tremendous load on their architecture—or rather on their infrastructure, it's super, super fun because you know that when you've done this, you have given that company more runway, or you've given them the things they need to actually be more successful, and so they can focus their time and efforts on growth and not on trying to stop the bleeding with their AWS bill.Corey: Tim, it's been an absolute pleasure to work with you. I'm going to miss working with you, but we are definitely going to remain in touch. Where can people find you to follow along with your continuing adventures?Tim: The best way to find me is on Twitter, I am @elchefe—E-L-C-H-E-F-E. And yeah, I will definitely keep in touch with you, Corey. Again, you have been a tremendous friend and I really appreciate you, your insights, and your honesty. Our partners are friends with each other and I do not think that they will let us ever drift too far apart. So.Corey: No, I think it is pretty clear that we are basically going to be both of their plus-ones forever.Tim: [laugh]. I think so.Corey: I'm just waiting for them when they pulled the prank of dressing us the exact same way because our styles are somewhat different, and I'm pretty sure that there's not a whole lot of convergence where we both wind up looking great. So, it's going to be hilarious regardless of what direction it goes in.Tim: Well, you do have velour tracksuits too, right?Corey: Not yet, but please don't tell that to Bethany.Tim: [laugh].Corey: Tim, it has been an absolute pleasure.Tim: The pleasure has been all mine, Corey. I really appreciate it.Corey: Tim Banks, for one last time, principal cloud economist at The Duckbill Group. I am Cloud Economist Corey Quinn, and this is Screaming in the Cloud. If you've enjoyed this podcast, please leave a five-star review on your podcast platform of choice, whereas if you've hated this podcast, please leave a five-star review on your podcast platform of choice and an insulting comment that says that we are completely wrong in our approach to management and the real answer is as follows, making sure to keep that answer less than 280 characters.Corey: If your AWS bill keeps rising and your blood pressure is doing the same, then you need The Duckbill Group. We help companies fix their AWS bill by making it smaller and less horrifying. The Duckbill Group works for you, not AWS. We tailor recommendations to your business and we get to the point. Visit duckbillgroup.com to get started.Announcer: This has been a HumblePod production. Stay humble.

Host: Mark Teresi. Dr. timone davis is an assistant professor of Pastoral Studies with an emphasis in Black Catholic Theology at Loyola University's Institute of Pastoral Studies. She is also Associate Convener with the Black Catholic Theological Symposium and author of the book, Intergenerational Catechesis: Revitalizing Faith through African-American Storytelling.

La sclérose en plaques est une maladie auto-immune affectant le système nerveux central en attaquant la gaine protectrice des neurones. Le système de défense censé protéger l'organisme contre les agressions extérieures se retourne contre ses propres cellules et les attaque pour des raisons encore mal connues. Quelle prise en charge pour les patients ? Où en est la recherche ? Pr Jean Pelletier, chef du service de Neurologie et Maladies inflammatoires du cerveau et de la moëlle épinière au CHU de la Timone à Marseille. Président du Conseil médico-scientifique de la Fondation ARSEP. Dr Ndiaga Matar Gaye, neurologue à la Clinique neurologique du Centre hospitalier national Universitaire de Fann de Dakar, enseignant-chercheur à la Faculté de Médecine de l'Université Cheikh Anta Diop de Dakar au Sénégal. Gwendoline Michenet, bénévole à la fondation ARSEP, fondation pour l'aide à la recherche sur la sclérose en plaques. Conseillère municipale déléguée au handicap à Nanteuil-lès-Meaux. Cette émission est une rediffusion. 

La sclérose en plaques est une maladie auto-immune affectant le système nerveux central en attaquant la gaine protectrice des neurones. La sclérose en plaques touche-t-elle davantage certaines populations ? Est-elle plus fréquente dans certaines régions du monde ? Pr Jean Pelletier, chef du Service de Neurologie et Maladies Inflammatoires du Cerveau et de la Moelle Epinière au CHU de la Timone à Marseille. Président du conseil médico-scientifique de la Fondation ARSEP. ► Retrouvez l'émission en intégralité ici.

Mike Isaacson: Now when you say recommended dose… [Theme song] Nazi SS UFOsLizards wearing human clothesHinduism's secret codesThese are nazi lies Race and IQ are in genesWarfare keeps the nation cleanWhiteness is an AIDS vaccineThese are nazi lies Hollow earth, white genocideMuslim's rampant femicideShooting suspects named Sam HydeHiter lived and no Jews died Army, navy, and the copsSecret service, special opsThey protect us, not sweatshopsThese are nazi lies Mike: Welcome to another episode of the Nazi Lies Podcast. Subscribe to our Patreon to get access to early episodes and membership in our book club and Discord. Today we are joined by Dr. Tim Geary, a pharmacoparasitologist or parasitopharmacologist… He studies parasites and makes drugs. He's a professor emeritus at McGill University and still teaches courses at Queen's University Belfast. He's here to talk to us about hydroxychloroquine, ivermectin, and why they probably won't neutralize Coronavirus. Thanks for joining us, Dr. Geary. Tim Geary: You're welcome, Mike. Please call me Tim. Mike: Okay, Tim. Before we get into all the science, tell our audience a little bit about what you've done professionally, because you have a very extensive list of bona fides, and I don't really know where to start. [laughs] Tim: That's quite all right. Yes, I have been working on the study of drugs, pharmacology, for about 45 years, and most of that time I've been working on chemotherapy of infectious diseases, primarily parasites. This includes work in Africa. Most of my career has been on veterinary parasites or human neglected tropical diseases caused by parasites. During the course of my career I have worked on malaria, and that's where chloroquine and its derivative hydroxychloroquine come from, and also ivermectin, which I have studied for many, many years, both in animals and people. In full disclosure, Mike, I once did work for the pharmaceutical industry, the animal health arm of a company called up Upjohn that is now known as Zoetis in Kalamazoo, Michigan. [ed. It's now part of Viatris.] I also consulted and worked with the World Health Organization, with the Bill and Melinda Gates Foundation, and with the Carter Center on various problems of tropical diseases, and I continue to be a consultant for some animal health companies. That's who I am. Mike: Very good. All right. Now you've done some research on both hydroxychloroquine and ivermectin, correct? Tim: I have, indeed. I worked on both how they work to kill parasites and also how parasites become resistant to them. I have studied them in clinical settings as well as in the laboratory, and I think I qualify as an expert in both medicines in the indications for which they are used, which is essentially tropical medicine and veterinary parasitology. Mike: Very good. And you've also been following the misinformation surrounding these two drugs too, right? Tim: I have, with great interest and concern. There aren't very many people in the world who are experts at drug discovery and drug development for these kinds of conditions. That's unfortunate. But yes, I have followed that, Mike, and I certainly have opinions about where the misinformation came from. It was not a malintention, it was just wrong interpretation and wrong design of some initial experiments that led to inappropriate conclusions in a rush to clinical use. Mike: Okay, so let's talk about each of these medications and then we'll talk about where the rumors started. So let's start with hydroxychloroquine. Since the beginning of the pandemic almost, it was heralded as a miracle COVID cure but was quickly discovered not to be that. What were its recognised clinical uses? Tim: So hydroxychloroquine is a derivative of a drug called chloroquine, which was also touted initially as a possible solution to COVID. Chloroquine was a miracle drug for the treatment of malaria. It saved, oh my gosh, millions and millions of lives over the course of its use. It's relatively cheap, it's reasonably safe and it was highly effective against malaria parasites until they evolved resistance to it. It's use for malaria has now diminished remarkably. Hydroxychloroquine was thought to be a safer alternative with a better sort of safety profile. But it never was really used for malaria. It just never displaced chloroquine. Instead, it found use as kind of an immunomodulator compound for people with systemic lupus erythematosus or lupus as it's commonly known, an autoimmune condition. So hydroxychloroquine for people with lupus does help to reduce symptoms, to reduce worsening of the disease, and it is a valuable drug for that purpose. Mike: Okay, and how safe is it to experiment with? Tim: Not very. I mean, it does have side effects, especially when you go over recommended dosing. We'll talk, I think Mike, in a little bit about how that relates to potential uses against COVID, if you like, but it's normal use in lupus patients, it's pretty well tolerated. But the doses are quite specific for that, and as with most medicines, it's safe when used appropriately. Mike: And what happens when it's not used appropriately? What kinds of symptoms can you... Tim: There are a variety; hearing loss is one that kind of stands out, but you can get imbalances, a sort of dizziness, classic nausea, vomiting, things like that. It's not a drug to be taken lightly. It's not as safe as many of the medicines that we use. But again, when it's used appropriately, it's fine. Mike: Okay, and how did the rumors start that this could be used to be COVID. Tim: So it's a classic story, Mike. So whenever a new condition surfaces, like COVID, there's a rush to test all the– what are known as the FDA registered medicines. These are medicines that have been approved for one use or another either by the US government or by the European agencies. It's always easier to adapt an approved drug for new indication than to register a completely new medicine. It's just way cheaper, way faster. So everyone turns to “What have we already approved just to see if by some unexpected chance it would also work in this new condition?” And that's what happened here. People can grow the SARS-CoV-2 virus in cell culture. So we grow it in cell culture and throw every compound that is registered and approved into those cultures to see, “Does any of them work?” And hydroxychloroquine and ivermectin, which we'll talk about, they came out of that effort. There's a serious flaw with the strategy in this case. I will say, Mike, sometimes it works. Sometimes you find something you didn't expect. I don't think we'll have time to go into those exceptions but there are some. So a key-- and this is sort of basic science and I hope it's okay for everybody-- but a big factor is the kind of cell that you use to grow the virus to test it. Scientists typically use for viral diseases, a cell called the vero cell, which was derived from an African Green Monkey kidney. The reason they use this cell is because most viruses grow really well in it, so it's quite easy to adapt a new virus to that system. The problem is, it's not representative of the kinds of cells that say SARS-CoV-2, the COVID virus infect. Those would be human lung cells, if you will. So yes, hydroxychloroquine works at relatively high concentrations against the virus in vero cells. But it turns out if you do the same experiment with cultures of human lung cells, it really doesn't work at all, because the virus enters those cells in a way that's different than how it infects vero cells. Had we done the experiment properly, which is to use cultures of human lung cells, we wouldn't be having this conversation, Mike, because no one would have advanced hydroxychloroquine as a potential cure. I hope that answers okay, and I hope it's clear. It's not that the scientists who did this work had evil intentions, they did not. It's just that they used the wrong cell type, and people drew inappropriate conclusions from the result. Mike: Okay, let's switch gears to ivermectin. There's actually been a lot of misinformation about ivermectin on both sides of the don't-try-this-at-home debate. So in addition to the people on one side claiming that ivermectin can cure COVID, on the other side, you have people who are reducing ivermectin to just a horse dewormer. Tim: [laughs] Yeah. Well, ivermectin, like chloroquine is a wonder drug. Okay? First of all, ivermectin has revolutionized the treatment of parasites in animals, and we should not discount it. So maybe its primary use is actually in the prevention of heartworm infections in people's pets. It revolutionized the treatment of this. It's an important and extremely useful drug, but it also is very useful in people. It has been donated– More than a billion doses have been donated by Merck for the treatment of individuals infected with a couple of parasites in poor areas of the world, one is onchocerciasis or river blindness and the other is lymphatic filariasis or elephantiasis. So we have a huge history of use of the drug. It can be given once a year for these infections or twice a year. It's enormously important in tropical medicine. It is a human medicine. It is very safe as used. It's also extremely potent. So it takes very little of the drug to have a beneficial therapeutic effect. Mike: And how safe is it to experiment with? Tim: At the use doses, it's quite safe. There are isolated incidences which would never happen to people in the United States, for instance, or in regions that don't suffer from parasitic infections like this. It's very safe, but it can be overdosed. It's possible. One of the things that's really important to know, and I mentioned that it's very potent, right? So you give tiny doses to people who suffer from these parasitic infections, but the solutions that we use to treat animals, because animals are so much bigger than people, like horses or cows, for instance, they contain much higher amounts of the drug. And inappropriately taking those medicines you can get an overdose that has serious lethal concentrations and lethal implications, for instance. I think there have been a couple of fatalities in the US. So it should never be taken outside of a prescription by a physician. Mike: Okay. And where did the rumors about this one start from? Tim: [laughs] Exactly the same place, Mike. Ivermectin works against the virus in cell cultures, in vero cell cultures. It does not work in cultures of human lung cells, so there's no basis to presume that either of these drugs act by inhibiting the virus. I will also say that the concentrations of ivermectin that are required to be active even in the vero cells are 100 times higher than what you would see in a human dosed with a therapeutic amount of the drug. It's not even clear to me that even massive overdoses would give you enough of the drug in your blood to actually have this beneficial effect. The other problem, of course, that happened is people said, "Well, it's doing other things,” same with hydroxychloroquine, that maybe it's not inhibiting the virus but it has an immunosuppressive or some beneficial effect on immunity to the virus. That's unproven. I know of no real evidence that therapeutic doses of ivermectin for sure have this effect. Hydroxychloroquine is a kind of immunosuppressant and that is certainly not an effect you would like to see in acute infection, initial infection, because you need the immune system to combat the virus. It's possible that at later stages of more serious infections, when sometimes the human immune response can be over aggressive and cause pathology. That's why dexamethasone, which is a steroid that's used to suppress the immune system, has therapeutic benefit. But there's no reason to think that hydroxychloroquine will have any benefit over and above dexamethasone. And in fact, as you know, clinical trials in hospitalized patients showed no benefit whatsoever from hydroxychloroquine. Mike: And I would assume it's the same for ivermectin. Tim: It is. I'm sorry. It is. It's the same for ivermectin that we have treated hundreds of millions of people and literally billions of animals with this drug. No one has ever reported an antiviral effect or an immunosuppressive effect in these individuals. So we don't really have a mechanism that would explain either one. This becomes very important. I'm going to take a segue here if you don't mind. Mike: Hey, go for it. Tim: So right now ivermectin is undergoing clinical trials, not because of science but because of sort of public demand. These include several trials in the United States. The problem with a clinical trial like this is we have no hypothesized mechanism. So we don't have any way to judge, “How much ivermectin should we give to these people? What dose do we use? How frequently do we give it?” We have no idea what the target plasma concentration or blood concentration of the drug should be to have a beneficial effect on COVID. This makes the trial design extremely difficult. And it's going to complicate the interpretation. Right now some people think you have to take ivermectin all the time, other people think, “No, no, you just take it when you get sick.” We don't have a theoretical or any basis in theory to account for any of these outcomes. Mike: Okay. Switching gears again, I imagine in your relief work, you've encountered a bit of treatment and vaccine hesitancy, right? Tim: I think, Mike, just as a citizen, not necessarily have I sought it out. [laughs] I will say I have given a couple of other interviews about this and at least one of them generated a lot of negative feedback on my character because clearly ivermectin is a lifesaver and I'm doing a disservice. But in terms of vaccine hesitancy, I think it's coupled with enthusiasm for hydroxychloroquine or ivermectin. It's a rather bizarre demonstration of human susceptibility to anecdote and conspiracy. I will say, look, a lot of people that advocate either one of these drugs are not evil. I think they're misguided. I'm looking forward to the results of the clinical trials on ivermectin that I hope will quell some of this over-enthusiasm. I don't believe they are malicious actors, they just are misinformed. There is no scientific rationale to advocate either of them. Vaccine hesitancy is a bit different. It's grounded in ignorance. There's a political component to it, which is difficult for me to accept, that somehow it threatens individual liberty to require people to protect each other. I find that a bizarre and unhealthy development in our society. I suppose it's always been there. There is no reason to fear the vaccine. They're well-grounded in science, all of the various pipes that have been advanced. They have all been approved after regular rigorous study. None of them has nefarious intent. There is no conspiracy among major pharma companies about this. I'm a little bit concerned that the medicines that have recently been approved, I think, one from Merck and one from Pfizer as antivirals, I think they're valuable. But it also gives people an opt-out for the vaccine to say, "Well, if I get sick I can get cured." That's unfortunate. I probably haven't answered your question, have I? Mike: Well, I was gonna ask what you find motivates the vaccine hesitancy and what motivates the hesitancy to believe medical professionals, if you've encountered that in your personal interaction with patients. Tim: I have. I mean, I don't treat patients. I want to be clear about that. I'm just a scientist. But of course I have lots of conversations in my life with some people who don't agree that vaccines are important. Some people don't agree that the virus is actually real. They think it's a hoax perpetrated, somehow, I don't know how. I'm gonna-- not being a sociologist, I'm not sure how valid my opinion is, but I think one of the factors is that most people don't know any scientists. They don't really know their physicians as people. We've become a customer-client medical system. You're probably too young to remember sort of the family doctor that would sit and chat. I know there's still some GPs that do that, but a lot of this is now assembly line. You show up, you don't even get 10 minutes, and you're on to the next patient. Right? People don't know physicians as people, they don't know scientists at all. The demise of the public school system in the US and the advance of private schools means that people who are scientifically literate often send their kids to private schools, and they don't get a chance to interact with, I'm just gonna say, non-scientists very much. They don't coach softball or baseball or football teams, they don't go to PTA meetings. Our dependence on electronic communications, as you and I are now doing, diminishes the opportunity for interpersonal interaction or casual just to say, "Hey, I do this for a living and you shouldn't be afraid of me and the people like me." But there is a distrust, especially in the Western countries-- actually, it's global. In the so-called elite, there is this distrust of intellectual output. I gotta tell you, just recently, the National Science Foundation released survey data of 30% of the scientists and engineers in the US are foreign born. And that's another barrier to communication; people tend to view foreigners with suspicion. So there's been a disconnect in American society between this incredible technology that drives our society and the people who benefit from it, or participate in it almost as unwitting, unwilling guinea pigs, right? That's a long winded answer, I hope it's okay. Mike: [laughs] Well, it's a good one. So what research are you working on now? Tim: One of the things that I have become fascinated by is how parasites manipulate their hosts. So a lot of my work is how the molecules that parasites release into their hosts affect the host response to allow them to succeed. Some of the parasites I studied live for many, many years in the host, large kind of parasites, and you'd think we should be really good at getting rid of them. And we are, in fact, really good at getting rid of almost every parasite, but some few species have figured out how to 'live long and prosper' as Mr. Spock would say, in our bodies. So I'm really curious about how they accomplish that. The other project I'm involved with at the moment is with the Carter Center, and it's about a worm, a parasite called guinea worm in Africa, which has nearly been eradicated, but it has recently been found to not only infect people but dogs, and so we're trying to come up with a medicine that can be used to treat the parasite in dogs so that eventually we can eradicate it. This is a parasite that Jimmy Carter has said, "I hope the last guinea worm dies before I do." Mike: And what does a guinea worm do? Tim: Oh my gosh, you want to really get grossed out? Your listeners, go look it up. It's a parasite called Dracunculus medinensis. It's the little dragon of Medina. It lives beneath the skin. The females get to be at least half a meter long or even longer, and they burrow out of the skin, and lay their eggs basically in water. It's disfiguring. It's very painful. It's an example of a gross parasite, I will say. But it can be cured or can be prevented if you keep people from going into the water. So this is kind of a behavioral solution that the Carter Center has really promoted. Or if you use filtered straws to drink. It infects people by drinking water that's contaminated with parasites. It's a lovely story. It would be a wonderful thing to eradicate, and I hope we can do it. Mike: Oh, really important work, Tim. Thank you so much for coming on the Nazi Lies podcast to teach us about drugs. This was fun. Tim: It's a pleasure. I think it's important to recognise, Mike, that people involved in fighting this virus are not motivated by malicious intent. They really are working to benefit people to try to get control of the epidemic, and they want everyone to get vaccinated. But thank you for inviting me, I sincerely appreciate the opportunity. Mike: Well, thank you so much. Tim: And another time perhaps, my friend. Mike: Absolutely. If you liked what you heard and want to support the Nazi Lies podcast, consider becoming a Patreon subscriber. Patrons get access to early episodes and membership in our book club. The early episodes can come in on any podcast app, and the book club is on Discord. Come join us as we read the books of our upcoming guests. It's a good conversation; your question may even end up on the show. Check us out at patreon.com/nazilies. [Theme song]